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Abstract 
This thesis describes a method involving the preparation of an L-proline-derived imidazolone 
protected with an N-triethylsilyl group that undergoes diastereoselective lithiation followed by 
electrophile quench to give C5-substituted products with syn stereochemistry. The N-silylated derivatives 
may be more easily N-deprotected as compared to previous N-t-Bu analogues to give secondary ureas. 
These may serve as precursors to N-phenyl chiral bicyclic guanidines or as NHC precursors for synthesis 
of corresponding complexes. 
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1. Introduction 
 
Saturated cyclic amines are a common structural motif in natural products and biologically active 
compounds, and an important template for versatile catalysts for a wide range of organic transformations. 
Piperidine and pyrrolidine heterocyclic amines occur widely in nature as constituents of quinolizidine, 
pyrrolizidine and indolizidine alkaloids, which exhibit interesting and diverse biochemical, 
pharmaceutical and agricultural properties as a result of their diverse biological activities.
1
 Prominent 
examples of these systems are natural compounds such as nicotine and coniine, anisomycin, oxiracetam, 
plakoridine, as well as the opiates codeine and morphine (Figure 1). 
 
            
 
 
 
 
 
Figure 1. Some biologically active nitrogen-containing heterocycles.
1
  
Achiral and chiral pyrrolidine heterocyclic amines are important structural motifs in potential 
catalysts for asymmetric synthetic chemistry and in natural products. Asymmetric lithiation is the most 
powerful synthetic method for synthesis of chiral pyrrolidine derivatives.
 2
  
2 
 
1.1. Direct α-Functionalization of Saturated Cyclic Amines 
 
The direct functionalization  of nitrogen-containing heterocycles has recently become an 
important route in organic synthesis.
2
 This is achieved with saturated cyclic amines by the addition of a 
protecting group to the nitrogen, α-lithiation, electrophilic substitution, and finally, deprotection of 
nitrogen.
3
 In fact, this straightforward way for direct α-functionalization of the saturated cyclic amines3 
has great utility in the alkaloid synthesis of potential pharmaceuticals and natural product synthesis.
4
 
Thus,
 
 this method may lead to further development of related compounds as potential medicinal agents. 
The direct functionalization of nitrogen-containing heterocycles can be derived by α-lithiation by 
alkyllithium and appropriate diamine complexes, production of active carbanion, followed by 
electrophilic substitution.
3 
Several protecting groups, including carbamates, formadines, oxazolines, 
amides and phosphoramides, were effective in α-functionalization of the nitrogen containing-
heterocycles, which were reported by Beak and Hoppe (Scheme 1).
5a,b
   
 
 
 
R = s-Bu, n-Bu, i-Pr 
PG = Boc, Et, n-Bu, i-Bu, CH2CH2OMe 
         trimethylallyl, 3-methylbut-2-enyl 
 
Scheme 1. Asymmetric deprotonation of N-protected pyrrolidines with chiral diamine and alkyllithium
4,5 
 
3 
 
O’Brien and co-workers have reported the asymmetric deprotonation of pyrrolidine by the use of 
(‒)-sparteine as a chiral diamine, which allows for removal of one of the pro-S protons. They also used 
other diamine ligands such as TMEDA, PMDETA as well as the (+)-sparteine surrogate, which have 
caused significant development in the α-lithiation strategy and provided a synthetic route to access both 
enantiomeric forms of α-substituted pyrrolidine derivatives (Figure 2).6 
 
 
 
 
Figure 2.  Structures (‒)-sparteine 9 and (+)-sparteine surrogate 10, PMDETA and TMEDA.6 
They have highlighted the importance and effectiveness of both (+)-surrogate and (‒)-sparteine in 
the asymmetric deprotonation with the opposite sense of enantioselectivity (Scheme 2). (+)-Surrogate 10 
was generated from cytisine 16 in excellent yield (Scheme 3).
7
 
                                     
 
 
 
 
Scheme 2. Influence of both (+)-sparteine surrogate and (‒)-sparteine in asymmetric deprotonation.7 
 
4 
 
 
 
 
 
 
 
Scheme 3. Synthesis of (+)-sparteine surrogate 10.
7
 
Pre-complexation of nitrogen with borane or boron trifluoride for the activation of tertiary amines 
to regioselective lithiation-substitution reactions play important role as a valuable method in organic 
synthesis.
8
 The most of studies in this area have focused on lithiation of sp
3
-hybridized carbon atoms 
alpha to nitrogen in cyclic amines such as Troeger_s base 18,
9
 isoindolines 19,
 10a,b 
pyrrolidines 20
11
and 
indolizidines 21,
12
 For these substrates 19 and 20, lithiation of prochiral α-methylene groups with 
alkyllithiums in the presence of the chiral diamine (‒)-sparteine after electrophile quench gave 
enantiomerically enriched products For example, (‒)-sparteine-mediated lithiation-substitution of 
isoindolines
 
gave products ranging from 78:22–94:6 er via intermediate 19. Under the same conditions, 
enantiomerically enriched carbanion 20 was generated in 85:15–86:14 er, determined as the 
benzophenone adducts (28–78% yield) (Figure 3). 
 
 
 
Figure 3. Previous examples of BF3- or BH3-activated lithiation of tertiary amines. 
5 
 
Metallinos and co-workers reported the first example of BF3-activated asymmetric lithiation of an sp
2
-
hybridized carbon atom of a prochiral aromatic amine, and the first application of bulky chiral 1,2-di-
aminocyclohexane ligands such as 22-24 in the BF3-activated tertiary aminoferrocenes, rather than (‒)-
sparteine. The process provided access to a broad range of enantiomerically enriched 2-substituted-1-
aminoferrocenes in high enantioselectivity (87:13 to 91:9 er) after simple recrystallization (scheme 4).
13
 
 
 
 
 
 
 
Scheme 4. Asymmetric lithiation of boron trifluoride-activated amino-ferrocenes. 
               Recently, this method has become more versatile by the development of (+)-sparteine surrogate 
10 and it is also now possible to install vinyl and aryl substituents with retention of stereochemical 
integrity of the chiral carbanion.
14
 The first synthesis of chiral benzylamines 29 from oxazolidones via 
diastereoselective lithiation was reported by Gawley and co-workers with good yields and excellent 
diastereoselectivities (Scheme 5).
15
                                            
                                                      
 
 
Scheme 5. Diastereoselective synthesis of chiral benzylamines from oxazolidones.
10
 
6 
 
Following diastereoselective lithiation procedure, Beak examined competition experiments 
between a series of N-Boc amines and bicyclic carbamates. The results indicated that rigid carbamates 
were deprotonated faster than N-Boc amines. Beak determined that these reactions undergo 
diastereoselective lithiation in the presence of a chiral centre in the substrate to give products 31 with syn 
stereochemistry (Scheme 6).
16
 
 
 
 
 
Scheme 6. Diastereoselective lithiation of bicyclic carbamate 31.
11
 
 It was indicated that removal of one of the pro-S protons is favoured and the resulting anion is 
configurationally stable. These results proposed that appropriate restriction of the geometry of the 
substrate can increase the ability of the lithiation reaction and a small dihedral angle between the carbonyl 
group and the proton that is being removed is favoured.  
The distance between the carbamate carbonyl group and the proton removed was calculated at the 
PM3 level.
11
These computational calculations showed that the pro-R proton had a much longer distance to 
the carbonyl oxygen (3.70 Å) than the pro-S proton (2.78 Å). Removal of the pro-S proton which is 
nearest proton to the carbonyl oxygen is kinetically, as well as thermodynamically favored (Figure 4).  
 
 
 
7 
 
 
 
 
 
Figure 4. Geometry between the lithium and the carbonyl group in cis and trans carbanions.
11
 
Following a similar procedure, Metallinos and co-workers reported in 2007
17
 asymmetric 
lithiation alpha to nitrogen of urea-fused piperidines by using i-PrLi (‒)-sparteine. According to the 
procedure described for bicyclic carbamates, an octahydrophenanthroline-derived urea 34 was lithiated by 
i-PrLi followed by electrophile quench to generate 35 in low yield and moderate enantioselectivities 
(Scheme 7). The transition state analysis for the lithiation of urea 34 by the i-PrLi and (‒)-sparteine 
complex was performed  at the MP2/G-31G(d)//B3LYP/6-316(d) level of theory, and showed that the 
removal of the axial pro-R hydrogen is less favoured than equatorial pro-S hydrogen.
12
  
 
  
 
 
 
 
Scheme 7. Lithiation of octahydrophenanthroline-derived urea 34.
12 
 
8 
 
Notably, they reported a new method to access enantiomerically enriched products of both 
pyrrolo[1,2-c]imidazolin-3-ones and pyrrolo[1,2-c]imidazol-3-ones, which are relatively challenging and 
problematic to make by conventional ways. They showed that 5-substituted pyrroloimidazolium and 
pyrroloimidazolinium precatalysts can be prepared in two steps by stereoselective lithiation followed by 
electrophilic quench of their lithio derivatives (Scheme 8).
18
 
 
 
 
 
        
Scheme 8. Synthesis of saturated and unsaturated ureas by stereoselective lithiation.
13
 
The next section will briefly introduce pyrrolidine-containing molecules which are used as 
catalysts in organic reactions.  
1.2. Guanidines  
 
Guanidines (Figure 5) are present in many natural products, which are often found to have 
significant biological activities
19
 as well their potential as substrate specific oxoanion hosts.
20
 Guanidines 
are obtained by the oxidation of guanine, synthesized for the first time by oxidative degradation of an 
aromatic natural product in 1861.
21
 
 
 
9 
 
  
 
Figure 5. General structure of guanidines. 
A large number of guanidines consist of marine guanidines, which are found as anionic receptors 
that can react with phosphates and carboxylates due to hydrogen bonding.
15
  
Guanidines are classified as organic superbases and catalyze a variety of base-assisted organic 
transformations due to the resonance stability of their conjugate acids. The guanidine compound, 1,1,3,3-
tetramethylguanidine (or N,N,N
׳
,N
׳
-tetramethylguanidine; TMG) 40 has been used in a wide  range of 
organic transformations as it’s substituted ones 41 used by Barton (Figure 6).22 
 
  
 
                                  
Figure 6. Structures of TMG 40 and Barton΄s bases 41.17 
1.2.1. Synthesis of Polysubstituted Acyclic and Monocyclic Guanidines and Their Applications 
TMG was synthesized for the first time by Schneck by treatment of 1,1,3,3-tetramethyl-2-
methylthioamidinium salt and ammonia in 1912  (Scheme 9).
23
  
 
10 
 
 
 
                                 
Scheme 9. Synthesis of guanidine 41 by Schenck.
18
 
  As an application of monocyclic guanidines, guanidine 44 was used by Ishikawa and co-workers 
to catalyze the Michael reaction of glycinate under solvent-free conditions, in which they obtained a high 
yield of 85% and good enantiomeric excess(ee). However, 48 only gave 49 in 79% yield and 55% ee, and 
required 3-5 days to reach completion (Scheme 10).
24
 
 
 
 
        
 
 
Scheme 10. Application of monocyclic guanidines in Michael reaction of glycinate.
19
 
 The hydroxyl group in the catalyst 44 was crucial for asymmetric induction in this process. 
Further attempts to optimize asymmetric induction were done by Ishikawa by using another monocyclic 
guanidine 50 in the asymmetric epoxidation of chalcone with different hydroperoxides. The result 
indicated epoxides 52 in 49% and 64% ees (Scheme 11).
25
 
 
11 
 
 
 
 
 
 
Scheme 11. Epoxidation of chalcone catalyzed by monocyclic guanidine 50.
20
 
 
1.2.2. Synthesis of Bicyclic Guanidines and Their Applications 
 
Corey and Grogen synthesized pseudo C2-symmetric bicyclic guanidines for the first time from 
(R)-phenylglycine and used it as a symmetrical bicyclic guanidine catalyst in a Strecker reaction in 1999 
(Scheme 12).
26
 A trityl-protected diamine was obtained by reacting methyl (R)-phenylglycinate with 
ammonia-saturated methanol to afford the desired amide. Subsequent to reduction of 53 by lithium 
aluminum hydride in ether, and coupling of 54 to CBz protected phenylglycine yielded amide 55. 
Conversion to triamine 56 was completed by carbamate hydrogenolysis, and reduction with sodium bis 
(2-methoxyethoxy) aluminum dihydride. Thiourea was generated by treatment of 56 with thiophosgene 
and aqueous sodium carbonate. After methylation with iodomethane, the desired guanidine 57 was 
obtained in a 55% yield after heating in DMF at 100 °C.  
 
 
 
 
12 
 
 
 
 
 
 
 
 
 
Scheme 12. Synthesis of pseudo C2-symmetric bicyclic guanidine 57.
21
 
  Ishikawa and co-workers used pseudo C2-symmetric bicyclic guanidine 58 in the TMS 
cyanation of aliphatic aldehydes and ketones, obtaining the products 60a,b with moderate enantiomeric 
excess (Scheme 13).
27
 
 
 
 
 
Scheme 13. Cyanation of aliphatic aldehydes and ketones catalyzed by pseudo C2-symmetric guanidine 
58.
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           In a following attempt, they applied the 1,3-dimethyl-4,5-bis(2-methylphenyl) imidazolidine and 
the related 1,3-dibenzyl-4,5-diphenylimidazolidine in the asymmetric Michael reaction of t-butyl 
diphenyliminoacetate and ethyl acrylate. The results showed good selectivity (79-98% ee). Also they 
found that selectivity and activity can be improved by installing the methyl group on the ortho position of 
the phenyl pendant in 1,3-dimethyl-4,5-bis(2-methylphenyl) imidazolidine and the related 1,3-dibenzyl-
4,5-diphenylimidazolidine (Scheme 14).
28
  
 
 
 
 
 
 
 
 
 
Scheme 14. Asymmetric Michael reaction of t-butyl diphenyliminoacetate and ethyl acrylate catalyzed by 
guanidines 61, 62, 63.
23
 
Kinetic resolution of sec-alcohols by silylation catalyzed by a variety of modified guanidines did 
not provide good selectivity, among them only 67a, 67b and 68 gave moderate enantioselectivity (31-
50% ee).
29 Ishikawa and co-workers improved selectivity when they used a bulkier triisopropylsilyl 
14 
 
chloride as a silylating agent (70% ee) as compared to tert-butyldimethylsilyl chloride (TBDMSCl) in 
reaction of indanol 69 (Scheme 15).  
 
 
 
 
 
 
 
 
Scheme 15. Reaction of indanol 68 with tert-butyldimethylsilyl chloride catalyzed by 67a, 67b and 68.
24
 
Quaternary carbon stereocentres are found in a wide range of organic compounds, including 
important medicinal agents and bioactive natural products. A variety of modified guanidines were 
examined in construction of quaternary carbon centres in the chromane skeleton by intramolecular oxa-
Michael addition.
30  
Good asymmetric induction was observed when Z unsaturated esters were used as the 
substrates in reactions catalyzed by (4S,5S)-2-[(R)-1-hydroxymethyl-2-phenylethylimino]-1,3-
dimethylimidazolidine 73 (Scheme 16). 
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Scheme 16. Construction of quaternary carbon centre by intramolecular oxa-Michael addition catalyzed 
by guanidines 72-76.
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1.2.3. DMC Chemistry 
 
           Chloroamidinium salts such as 2-chloro-1,3-dimethylimidazolinium chloride (DMC) and 
N,N,N’,N’-tetramethylchloroformamidinium chloride are strong  dehydration agents, and can chlorinate 
alcohols and  reduce sulfoxides.
31
 DMC is stable toward moisture and oxygen. Chloroamidinium salts 
have two advantages: 1) the easy removal of the excess starting material and regenerated salt by work-up, 
and 2) straightforward preparation (Scheme 17). DMC 79 is generated by reaction of 80 with phosphoryl 
chloride, oxalyl chloride or trichloromethyl chloroformate. 
16 
 
 
 
 
 
 
 
Scheme 17. Conversion of DMI to DMC and vice versa. 
           Guanidines can be synthesized by reaction of DMC with the appropriate amines. Thus DMC 
chemistry has developed into a methodology for obtaining both mono and bicyclic guanidines. Scheme 
18a shows the synthesis of trisubstituted monocyclic guanidines via the reaction of DMC-type 
chloroamidine compounds with amines.
 
Scheme 18b shows cyclization of guanidines by DMC 
chemistry.
32a,b   
 
 
 
 
Scheme 18a. Synthesis guanidines via reaction of DMC-type chloroamidine compounds.
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Scheme 18b. Cyclization of guanidines by DMC chemistry.
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1.2.4. Guanidines as Synthetic Tools 
Chiral guanidines have been used as potential catalysts in numerous asymmetric transformations. 
Ishikawa, in 2005, designed several polymer-based chiral guanidines and used them in the asymmetric 
Michael reaction of t-butyl diphenyliminoacetate with MVK (Scheme 19).
33
 
The turnover was observed to range from low to good enantioselectivity. In the case of polymer-
supported guanidine 90, no selectivity was observed. This might be caused by the steric hindrance around 
the active site due to the polystyrene group directly attached to the guanidine. A Michael reaction in the 
presence of catalyst guanidines 92 and 93 afforded moderate selectivity. (Scheme 19). 
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Scheme 19.  The turnover of the polymer-based chiral guanidines in asymmetric Michael 
reaction of t-butyl diphenyliminoacetate with MVK 95.
28
 
The development of active chiral catalysts for the borane-mediated asymmetric reduction of 
prochiral ketones has attracted much attention due to the applications of homochiral secondary alcohols in 
organic and medicinal chemistry. Basavaiah and co-workers applied guanidine 97 in the borane-mediated 
reduction of phenacyl bromide (Scheme 20).
34
 They reported that higher enantioselectivity values were 
achieved when the reaction was done in reflux conditions as compared to room temperature.  
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Scheme 20. Reduction of phenacyl bromide catalyzed by guanidine 97.
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1.3. NHC Carbenes 
 
Carbenes are classified as Lewis bases, which act as excellent σ-donors and poor π-acceptors. 
Although they are often less economical and environmentally friendly than other metal-free catalysts, N-
heterocyclic carbenes (NHCs) belong to the family of nucleophilic carbenes, which are known as 
organocatalysts and are considered as excellent ligands for metal-based catalysis.
35
. Most heterocyclic 
carbenes are stable and can be isolated. Deprotonation of imidazolium or imidazolinium salts with a 
strong base such as sodium hydride, potassium hexamethyldisilazane, (KHMDS) or potassium tert-
butoxide (KOt-Bu) (Scheme 21a). This approach was used by Arduengo in the original isolation of a free 
carbene.
36
 Alternatively, the desired carbene species can be thermodynamically generated from the related 
2-trichloromethyl, 2-pentafluorophenyl, 2-carboxylated, or 2-dithiocarboxylated “protected” NHC 
adducts (Scheme 21b) .
37a.b 
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Scheme 21a,b. Generation of free NHC carbene ligands by two methods.
31,32ab
 
1.3.1. Application of N-Heterocyclic Carbenes in Asymmetric Organic Reaction 
 
N-Heterocyclic carbenes (NHCs) can act as effective nucleophilic catalysts in organic reactions. 
Rovis reported synthesis of quaternary stereocenters by using triazolium catalysts.
38
 The 1,4-dicarbonyl 
compounds were generated in high yield and enantioselectivity under mild conditions. Moreover, the 
effect of a series of the aminoindanol-derived catalysts 105 in construction of the quaternary stereocentre 
of compound 107 determined that in all cases tertiary ether 107 was generated in excellent 
enantioselectivity (Scheme 22). Attempt to the synthesis of the 1,4-dicarbonyl compounds using the less 
activated olefin (R = Me) in methyl ester 110 failed, but compound 110 with CO2Me group gave bis-
methyl ester 111 in 78% yield and 65% ee (Scheme 23).  
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Scheme 22. Synthesis of quaternary stereocenters by using triazolium catalysts.
33
 
                
 
 
 
 
 
 
Scheme 23. Cyclization of bis-methyl ester catalyzed by 108 and 109.
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Aoyama designed a new class of N-heterocyclic carbene ligands for asymmetric catalysis in the 
Pd-catalyzed intramolecular α-arylation of anilides for generation of 3,3-disubstituted oxindoles with 
moderate enantioselectivity (Scheme 24).
39
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Scheme 24. Intramolecular α-arylation of anilides catalyzed by N-heterocyclic carbene derived from 12.34 
Hartwig and co-workers highlighted the application of a large number of chiral ligands in Pd-
catalyzed intramolecular α-arylation of anilides to give 3,3-disubstituted oxindoles.40 In this case, chiral 
bidentate phosphine ligands did not give good selectivity. Several groups tried to improve selectivity of 
this reaction including Glorius,
41
 but only moderate selectivity was obtained. Bulky t-Bu groups at the 
stereogenic centres to nitrogen gave moderate enantioselectivity. Ortho-substituents on the phenyl ring 
played key roles in the enantioselective formation of the product and obtained good enantioselectivity 
(Scheme 25).
42
 
 
 
 
 
 
 
Scheme 25. Several Pd-catalyzed asymmetric intramolecular α-arylation of anilides by using chiral NHC 
ligands.
35,36,37
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An E-selective catalytic method for preparation of Si-containing alkenes through protosilylation 
of terminal alkynes was reported by Hoveyda.
43
 They also demonstrated Cu-catalyzed copper–boron 
additions to vinylsilanes derivatives catalyzed by N-heterocyclic carbene copper complexes to generate 
vicinal or geminal borosilanes (Scheme 26).
 
 
 
 
 
 
 
 
 
 
Scheme 26. Formation of vicinal or geminal borosilanes catalyzed by an N-heterocyclic carbene.
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1.3.2. N-Heterocyclic Carbene Metal Complexes 
1.3.2.1. Historical perspective  
Complex of 124 was the first example of transition metal carbene which was reported by Fischer 
and Maasböl.
44
 Since their landmark report in 1964, transition metal carbene complexes in inorganic 
chemistry have become of great interest. 
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In 1968 the first syntheses of NHC metal complexes 125 and 126 were reported by Wanzlick
 
and 
Öfele (Figure 7).
31,45 
Then Schrock in 1974, developed a new type of carbene with a different reactivity, 
called the Schrock carbenes,
 46
 which are identified by more nucleophilic carbene carbon centres; these 
species mainly feature higher valent metals. 
 
 
 
 
Figure 7. The first examples of a transition metal carbene complex.
31,39,40
 
N-Heterocyclic carbenes are σ-donor ligands, NHC ligands have been considered to be mainly 
inert. This inert property is the reason for their resistance to oxidation and thermal stability. In 1993, 
Öfele and co-workers showed that the metal-carbon bond in NHC complexes, trialkylphosphanes and 
alkylphosphinates have the same bonding properties.
47
                  
1.3.2.2. Complexation to Metals 
Different synthetic routes have been discovered for the synthesis of NHC metal complexes such 
as using external base,
48
 transmetalation,
49
 oxidative addition
50
 and co-condensation.
51
 
Öfele utilized an anionic carbonyl hydride complex in the synthesis of the first M-NHC 
complex.
40
 The basic metalate ion [HCr(CO)5]
‒  
deprotonated an imidazolium salt to afford the M-NHC 
complex. Du Pont reported the first 14-electron carbene complexes with two-fold coordinated Ni(0) and 
Pt(0) were synthesized in 1994 via reaction of a metal precursor with carbene in appropriate solution.
52
 
Cloke reported the first homoleptic zerovalent carbene complexes by co-condensation of NHCs with 
metal vapor in reasonable yields.
46
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 The NHC complexes can also be synthesized by the reaction of imidazolinium or imidazolium 
salts with an external proper bases.
43
  
In the second generation of ruthenium-NHC complexes, Grubbs and co-workers highlighted  
deprotonation of the imidazolinium salts by using potassium hexafluoro-tert-butoxide as the external 
base, followed by direct complexation of the in situ-generated NHCs at room temperature (Scheme 27).
53
    
 
 
 
 
 
Scheme 27. Synthesis of NHC-complexes by deprotonation of imidazolinium salt with external base.
48 
Silver N-heterocyclic carbene complexes have played an important role in the development of 
metal-carbene systems. Deprotonation of imidazolium or imidazolinium salt by use of a silver base has 
been the most widely used method in the synthesis of N-heterocylic carbene complexes of silver. Silver 
NHCs could be synthesized from different silver sources.  In 1997, Bertrand used silver acetate in the 
synthesis of a silver-NHC from triazolium salts.
54
 In 2000, Danopoulos reported application of silver 
carbonate in the formation of silver NHCs.
55
 In 2007, synthesis of silver NHCs by using Ag2O was 
reported by Wang and co-workers.
56
  
 Silver N-heterocyclic carbenes have attracted much attention in the development of other NHC 
complex systems by way of transmetalation reactions. Transmetalation reactions using silver NHCs have 
been reported for a large number of transition metals: Ir(I), Ir(III), Cu(I), Cu(II), Pd(II), Ru(II), Ru(III),  
Ru(IV), Pt(II), Au(I), Rh(I), Rh(III), and Ni(II). Recent reviews dealing with transmetalation reactions 
26 
 
using silver NHCs have been published by Lin.
57
 For example, Gimeno reported synthesis of silver(I)–
NHC complexes for transmetalation to gold-NHC complexes (Scheme 28).
58
 
 
 
 
 
         Scheme 28. Example of using silver (I) transmetalation in formation of  NHC complexs.
53
 
Following oxidative insertion, metal–diaminocarbene complexes were synthesized by Fürstner 
and colleagues by oxidative insertion of [Pd(PPh3)4] or [Ni(COD)2] with PPh3 into the C-Cl bond of 2-
chloro-1,3-disubstituted imidazolinium salts(Scheme 29).
59
 
 
 
 
 
 
   
                         
Scheme 29. Synthesis of NHC-complexes by oxidative addition.
54 
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A lithium-halogen exchange route has been used to prepare different kind of complexes via one 
pot transmetalation. This method has been developed by Hong and co-workers in the synthesis of acyclic 
diaminocarbenes via lithium-halogen exchange (Scheme 30).
60
 
 
 
 
 
 
 
 
 
Scheme 30. Synthesis of NHC-complexes by a lithium-halogen exchange.
55
 
1.3.2.3. Application of NHC-complexes 
 In 1996 Enders applied chiral carbenes in the the first asymmetric intramolecular Stetter 
reaction.
61
 Since then, different kinds of chiral NHC ligands have been used in various asymmetric 
reactions. The following section will describe some examples of the application of chiral NHC ligands in 
asymmetric organic reactions. Several attempts have been performed for achieving good selectivity by 
using chiral NHC-complexes in asymmetric organic reactions. Several kinds of metals were used for the 
synthesis of NHC-complexes and applied in asymmetric organic reactions.  
Several chiral rhodium-NHC complexes have been prepared and found useful in asymmetric 
organic reactions. Helmchen designed rhodium-NHC complexes with the combination of two different 
28 
 
backbones, including a rigid 2-(diphenylphosphino)naphthyl group connected to the dihydroimidazole 
moiety via a stereogenic axis to one nitrogen and a phenyl group with an i-Pr-substituent to the other 
nitrogen.
62 
These are disposed anti- to the phenyl groups of the dihydroimidazole moiety on another side 
in the asymmetric hydrogenation of substrates dimethyl itaconate and N-acetyldehydroamino acid 
derivatives (Scheme 31). 
 
 
 
 
 
                                
 
Scheme 31. Asymmetric hydrogenation catalyzed by (S,S)-139.
57
 
A year later, Helmchen used this catalyst in asymmetric conjugate additions of arylboronic acids 
to enones and α,β-unsaturated esters.63 The results showed of arylboronic acids to enones and α,β- 
unsaturated esters excellent catalytic activity in conjugate additions of phenylboronic acids due to steric 
and electronic properties of the catalyst (Scheme 32). 
 
 
 
 
Scheme 32.  Conjugate addition of phenylboronic acid to α,β-unsaturated ester catalyzed by (S,S)-139.58 
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 In 2005, Grubbs and co-workers won the Nobel Prize for development of olefin metathesis in 
organic reactions. Grubbs reported the first enantioselective olefin metathesis by using NHC catalysts in 
the desymmetrization of achiral trienes with high enantiomeric excess (Scheme 33).
50 
 
                 
 
 
 
 
Scheme 33. Desymmetrization of achiral trienes catalyzed by Grubbs’ catalyst.50 
Several N-heterocyclic carbene ligands have been applied in the copper catalyzed 1,4-addition of a 
dialkylzinc reagent to an unactivated β-substituted cyclicenones.64 Recently, selective allylic substitutions 
by using copper derivatives and Grignard or dialkylzinc reagents catalyzed by N-heterocyclic carbenes as 
ligands have been reported.
65 
Roland and Alexakis reported an enantioselective copper catalyzed 1,4- 
conjugate addition reactions by using chiral diaminocarbenes as ligands in silver complexes.
66
 Analysis of 
the catalytic data demonstrated the effect of low temperature conditions using diethyl ether and CuTC 
was superior in terms of enantiomeric excess for this reaction, and also higher selectivity was observed 
when they employed the m-OMe substituted analogue 151. The corresponding adduct was obtained in a 
100% yield with an enantiomeric excess of 88% (Scheme 34). 
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Scheme 34. Addition of Et2Zn to cyclohexenone catalyzed by 150, 151.
61
 
An attempt to synthesize NHC-palladium complexes with a chiral N-heterocycle and naphthyl 
side chains by Dorta gave three different isomers, which were separated successfully and applied in the 
asymmetric intramolecular α-arylation of amides, leading to the formation of oxindoles containing 
quaternary carbon centres in high yield and high enantiomeric purity.
67
 The results showed that 
orientation of the aromatic side chains had an effect on selectivity in this reaction. Oxindoles with 
quaternary carbon centres were formed with high yield and selectivity (86% ee) when [(Ra,Ra)-154] was 
applied (Scheme 35).  
 
 
 
 
 
 
 
 
 
Scheme 35. Intramolecular α-arylation of amides catalyzed by NHC-palladium complexes 154.62 
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The first example for the application of chiral rhodium(I)-NHC complexes as enantioselective 
hydrosilylation catalysts was reported by Herrmann and co-workers.
68
 In 2009, they considered the 
catalytic activity and selectivity of the rhodium(I) complex for the hydrosilylation of prochiral ketones. 
The result showed only significant enantioselectivity (73% ee) being obtained with 4-
(trifluoromethyl)acetophenone at ambient temperature (Scheme 36).
69
 
 
 
 
  
 
 
 
Scheme 36. Hydrosilylation of prochiral ketones by catalyst 157.
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1.4. Aims and Objectives 
 
There have been a number of previous attempts via lithiation–substitution of t-Bu protected ureas 
to afford series of C5-substituted products with syn stereochemistry,
70
 but there were two challenges in 
synthesis of N-substituted products. The first challenge was generation of inconstant yields upon scale up. 
The second was the harsh reaction conditions required for deprotection of the C5-substitution product 
159, such as reflux for 48 hours with trifluoroacetic acid, which posed stability issues in some 
derivatives.
65
 These issues encouraged us to explore a viable synthetic method to synthesize an L-proline 
hydantoin-derived N-silyl protected version of 159, which undergoes analogous diastereoselective 
lithiation and substitution to obtain substituted products that may be readily N-desilylated with dilute acid 
at room temperature to generate secondary ureas (Scheme 37). 
 
 
 
 
 
 
 
Scheme 37. N-deprotection of compounds 159 and 162. 
The ureas 163 undergo N-arylation leading to chiral pyrroloimidazolinones, which undergo 
POCl3 or (COCl)2 activation to generate the target biological active compounds. Treatment of compound 
163 with POCl3 will afford chiral annulated chloroimidazolinium salts 164, which can be applied as an 
intermediate for the synthesis of chiral guanidines 165 by using the appropriate amines (Scheme 38). 
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Scheme 38. Proposed method to synthesize guanidine 165. 
The chiral urea 166 will also be converted to the compound 167 via reduction by DIBAL-H in 
THF at ‒78 °C. The chiral aminal 167 will undergo salt formation by oxidation to give 168, which may 
serve as a precursor to NHC 169 by using external base. The resulting NHC ligands will be used for 
formation of transition metal complexes 170 (Scheme 39). 
 
 
 
 
 
 
                                     
Scheme 39. Proposed method to synthesize complex 170. 
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2. Results and Discussion 
2.1. Preparation of 2-Triethylsilyl-hexahydro-pyrrolo[1,2-c]imidazol-3-one 
The L-proline hydantoin is synthesized from readily available starting materials and its 
application as a precursor to a chiral auxiliary for diastereoselective lithiation of ferrocenes
71
 made it an 
attractive starting material for the synthesis of C5-substituted imidazolinones. L-proline hydantoin was 
prepared easily from L-proline 171 in the presence of potassium cyanate in water, followed by treatment 
with 6 M aqueous HCl in 61% yield (Scheme 40).
72 
 
 
 
 
Scheme 40. Synthesis of L- proline hydantoin from L-proline.
73
 
The proline hydantoin was reduced with lithium aluminium hydride in THF at room 
temperature
73
 to give compound 161 in moderate yield (56 %). Compound 161 was prepared in large-
scale without racemization of the pyrrolidine chiral centre (Scheme 41). 
   
 
 
                                                                  
 
Scheme 41. Synthesis of compound 161. 
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Based on previous research in ortho lithiation by Hoppe,
74
 imidazolinone 161 was initially N-
protected by deprotonation of nitrogen with i-PrLi/TMEDA, followed by addition of TMSCl. Although 
product 174 was air-stable and could be purified by flash column chromatography, subsequent attempts to 
induce diastereoselective lithiation at the C5 position by sequential treatment with i-PrLi and TMEDA at 
−78 °C in diethyl ether, followed by TMSCl quench, resulted in the formation of the N 
[bis(trimethylsilyl)methyl]dimethylsilyl product 175 (Scheme 42). 
 
 
 
 
Scheme 42. Formationof N-[bis(trimethylsilyl)methyl]dimethylsilyl compound 175. 
The observed regiochemistry was presumably due to the greater acidity of the α-silylmethyl groups over 
the C5 position. This result was in contrast with the behavior of N-trimethylsilyl protected aryl-O-
carbamate 177 reported by Hoppe,
69 
which gave phenol 179 by ortho lithiation after electrophile quench, 
deprotection and hydrolysis of the secondary carbamate 177 (Scheme 43).     
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Scheme 43. N-trimethylsilyl protected aryl-O-carbamate 177.
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To prevent α-silyl carbanion formation, triethylsilyl chloride was used with the expectation that 
the α-silyl methylene groups would be less prone to deprotonation (Scheme 44). 
 
 
                                                 
                                    
                                             
Scheme 44. N-protection of compound 161. 
2.2. Diastereoselective Lithiation-Substitution of Compound 159 
Computational studies were done on 159 to determine the distances between the urea oxygen 
atom and the pro-S and pro-R alpha methylene hydrogens. The results showed that the pro-S proton alpha 
37 
 
to nitrogen was closer to the carbonyl oxygen (2.505 Ǻ) compared to the pro-R proton (3.692 Ǻ);13 
lithiation will take place at the pro-S proton over the pro-R proton because of the shorter distance between 
the alkyllithium base to that hydrogen upon coordination to oxygen (red = oxygen, blue = nitrogen, white 
= hydrogen, grey = carbon) (Figure 8). The structure of compound 159 was optimized at the B3LYP/6-
31G(d) level as implemented in Gaussian 03.
13
 
 
 
 
 
 
 
 
 
Figure 8. Minimum energy structure of 159.
13
 
The first attempt of diastereoselective lithiation of compound 162 was done by using i-PrLi and 
TMEDA and Et2O in ‒78 °C followed by electrophilic quench. sec-BuLi was also examined for this 
reaction based on previous research, which was done by our group for diastereoselective lithiation of tert-
butyl N-protected urea (2-tert-butyl-hexahydro-pyrrolo[1,2-c]imidazol-3-one) 159 (Scheme 45).
13
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E = Ph2COH, Me, allyl, SnMe3, SiMe3, CO2H 
Scheme 45. Diastereoselective lithiation of compound 159.
13
 
Several electrophiles were used for diastereoselective lithiation of compound 162 (Scheme 46), 
such as dimethyl sulfate, trimethylsilyl chloride, benzophenone and tributyltin chloride (Table 1). These 
reactions gave moderate to good yields and single diastereomers, which were determined by 
1
H and 
13
C 
NMR analysis. All obtained products are exclusively in the syn configuration, which is proven by NOE 
spectroscopy. 
                                                                
 
 
 
Scheme 46. Diastereoselective lithiation of compound 162. 
Table 1. Results of diastereoselective lithiation of compound 162. 
 
 
 
 
                                                           *via CuCN·2LiCl transmetalation. 
Allylation of 162 by transmetalation of the alpha lithio intermediate with a mixture of copper cyanide and 
lithium chloride in the presence of TMEDA gave 31% yield. Surprisingly, a slightly better yield was 
obtained when the reaction was performed without TMEDA (47%) (Scheme 47).  
compound E
+
 E yield % 
181 Me2SO4 Me 65 
182 Ph2CO C(OH)Ph2 61 
183 allyl bromide* allyl 47 
184 SiMe3Cl SiMe3 86 
185 SnBu3Cl SnMe3 60 
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Scheme 47. Transmetalation of alpha lithio intermediate for allylation. 
Several attempts were made with different kinds of electrophiles such as benzaldehyde, dimethyl 
disulfide and 3-bromocyclohexene, but no product was produced (Scheme 48). 
 
 
 
                                                                 
 
                                       Scheme 48. Several attempts to diastereoselective lithiation 
Several reaction conditions were examined to optimize the reaction conditions. For example, 
different kinds of lithium species and solvents were tested. The results showed that i-PrLi and Et2O were 
superior in terms of yield in the diastereoselective lithiation reaction. Stereochemistry of all these 
products was confirmed by NMR spectroscopy. For example, analysis of 181 by HSQC showed the 
proton connected to the corresponding carbon atom to identify the proton-carbon connectivities, then 
NOSEY or NOE showed that the methine protons of interest of chiral centres were on the same side of 
the molecule, a correlation cross peak between these same methine protons of chiral centres (indicated by 
arrows) was obtained (Figure 9). 
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Figure 9.HSQC spectrum of 181. 
For example, in the 1D-NOE of 181, irradiation of a proton from the pyrrolidine methine groups 
at 1.91 led to enhancements of the key methane proton (indicated by arrows) at 3.98 and irradiation of a 
proton at 3.98 lead to enhancement of the key methane protons at 3.69 and 1.91 ppm respectively (Figure 
10). Similar enhancements were observed in the 1D-NOE spectra of 182, 183, 184, 185.  
 
41 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. 1D-NOE of 181. 
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2.3. N-Desilylation of secondary ureas 
Deprotection of the N-t-Bu group on the C5-substituted compound 159 requires harsh reaction 
conditions, such as using trifluoroacetic acid in reflux for 48 hours, which may lead to stability issues for 
certain derivatives (Scheme 37).
12
 Products 181-185 underwent smooth N-desilylation upon treatment 
with 2M aqueous HCl for 30 min at room temperature to give secondary ureas 186-190 in good yields 
(71-91%). It is notable that potentially sensitive substituents, such as the diphenylhydroxymethyl group of 
182 or the stannane of 185, remained intact under these conditions (Table 2).                                  
 
 
 
                                                       Table 2. Results of N-desilylation.  
                                           
                                                                              
                                                                
       
 
 
 
 
 
compound   product         E Yield % 
181      186        Me    84 
182      187        Ph2COH    80 
183      188        allyl    82 
184      189        SiMe3    91 
185      190        SnBu3    71 
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2.4. N-Alkylation  
The ability to remove the N-TES group in the preceding products allows for the introduction of 
new N-substituents. For example, compound 189 underwent N-alkylation by using sodium hydride and 
methyl iodide in DMF at 0 °C to room temperature (Scheme 49). 
 
 
                                              
                                             
Scheme 49. N-alkylation of compound 189. 
2.5. N-Arylation 
 
Leung reported synthesis of symmetrical and unsymmetrical N-aryl-substituted cyclic ureas by 
employing copper(I) iodide and ligand in toluene in the presence of base (Scheme 50).
75 
Leung mentioned 
that ligands play an important role in the reactivity of copper catalysts in this reaction. They examined 
different ligands such as trans-N,Nˊ-dimethylcyclohexane-1,2-diamine (DMCHDA) and trans-
cyclohexane-1,2-diamine (CHDA) with different bases and solvents (Table 3). 
 
 
 
                                  Scheme 50.  Synthesis of N-aryl-substituted cyclic urea 193.
70
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                                  Table 3. Results of the N-arylation of cyclic urea 193. 
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A Goldberg–Buchwald–Nandakumar C–N coupling, using different diamine ligands, such as 
cyclohexane-1,2-diamine (CHDA) and tetramethylethylenediamine (TMEDA), with copper(I) iodide, 
potassium carbonate, iodobenzene in toluene at 110 °C for 48 h, provided the desired coupling product 
(Scheme 51). N-Arylation of compounds 186 and 189 by employing CHDA gave low yields (5-20%). N-
phenylation of either 186 or 189, with a mixture of copper iodide and TMEDA, gave better yields (40-
74%) (Table 4). 
 
 
 
Scheme 51. N-Arylation of compound 186 and 189. 
Table 4. Results of N-arylation of compounds 186 and 189. 
      
 
 
Entry Base Diamine ligand Yield 
(%) 
1 K3PO4 CHDA 2 
2 K2CO3 CHDA 62 
3 Cs2CO3 CHDA 19 
4 K3PO4 DMCHDA 54 
5 K2CO3 DMCHDA 92 
6 Cs2CO3 DMCHDA 44 
Entry Compound Diamine ligand Product Yield 
(%) 
1 186 CHDA 166 20 
2 189 CHDA 194 5 
3 186 TMEDA 166 74 
4 189 TMEDA 194 40 
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Lithiation of compound 166, using i-PrLi in the presence of TMEDA in THF at ‒78 °C followed by 
electrophilic quenching, gave the desired ortho-substituted product (Scheme 52). Compounds 195 and 
196 were obtained in 67% and 47% yields. Asymmetric lithiation with other lithium species, such as n-
BuLi and t-BuLi, failed.  
 
 
 
 
Scheme 52. Synthesis of ortho substituted ureas 195 and 196. 
N-Arylation of the bulky urea 187 under the same conditions as Scheme 52 gave compound 197 in a 49% 
yield (Scheme 53). 
 
 
 
 
                                               Scheme 53. N-Arylation of compound 187.                                        
The hydroxyl group of 197 was subjected to protection to prevent side reactions of the hydroxyl group in 
the next step, which consists of guanidine formation with POCl3. Protection of the hydroxyl group in 
compound 197 via alkylation with an excess amount of methyl iodide at room temperature failed. 
Protection of the hydroxyl group also failed using dimethyl sulfate under reflux conditions (Scheme 54).  
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Scheme 54. Attempted protection of compound 197. 
Compound 199 was synthesized with hexafluorobenzene and sodium hydride in DMF, due to significant 
rate enhancement in the catalytic performance of metal–NHC catalysts bearing fluorinated aryl groups on 
the NHC ligand.
76
 We observed the formation of compound 199 in 35 % yield and by-product 200 in 23% 
yield (Scheme 55). 
 
 
                                           
                                                
                                         
                                             
 
Scheme 55. Synthesis of compound 199 and 200. 
2.6. Guanidine Formation by POCl3 Activation and Their Applications in Catalysis  
Compound 191 was converted to the 3-chloroimidazolinium salt by using excess amounts of neat 
phosphoryl chloride at 110 °C. In this process, the intermediate 3-chloroimidazolinium salt 201 could not 
be isolated, and was therefore exposed without further purification to benzyl amine and triethylamine in 
acetonitrile to give the desired guanidine 202 (Scheme 56).  
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Scheme 56. Synthesis of guanidine 202 by POCl3 activation. 
 The guanidine formation of compounds 202 and 203 by using ureas 166 and 191 gave moderate 
yields of 35% and 61%, respectively (Scheme 57). The 
1
H NMR analysis showed a large number of 
broad peaks, which converted to the clear corresponding peaks after heating at 120 °C. This process 
indicated the presence of two isomers for compounds 202 and 203, which were slowly interconverting via 
isomerization about a C=N bond via an inversion of the nitrogen substituent.  
. 
 
 
 
 
Scheme 57. Synthesis of guanidines 202 and 203. 
 Guanidine 204 bearing a hydroxyl group was obtained in 31% yield to use of hydrogen bonding 
interactions to accelerate and control organic reactions, and also this hydrogen bonding can be used to 
stabilize anionic intermediates and transition states (Scheme 58). 
 
 
48 
 
 
 
 
Scheme 58. Synthesis of compound 204. 
Compound 205 was synthesized by using aqueous ammonia and triethylamine in 30% yield 
(Scheme 59). Then ureas 166 and 194 were converted into the corresponding guanidine products by the 
same synthetic method as used in the synthesis of 205. This reaction gave 206 and 207 in 41% and 34% 
yields (Table 5). 
 
 
 
Scheme 59. Synthesis of guanidine 205. 
 
 
 
                                    
Table 5. Results of synthesis of compounds 206 and 207.                         
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             The formation of compound 208 in neat POCl3 at 110 °C failed and only the starting material 
was recovered (Scheme 60). 
 
 
                                                           
            
 
Scheme 60. Attempted salt formation of compound 199. 
 
2.7. Application of Guanidines 
           Previous studies by Ishikawa and co-workers showed that the Michael addition of cyclopentenone 
with dibenzyl malonates catalyzed by guanidine 209, resulted in moderate to good asymmetric inductions 
(Schemes 61, 11).
77
 
 
 
 
 
 
     
                                                                                                                           
       Scheme 61. Reaction of cyclopentenone with dibenzyl malonates catalyzed by guanidine 209.72 
            To improve the enantioselectivity of the reaction depicted in (Scheme 61) by addition of a chiral 
centre at alpha position and also presence a hydroxyl group functionality  at catalysts, guanidines 202, 
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203 and 204 were employed in the Michael addition of dimethyl malonate with cyclopentenone in solvent 
free conditions. The results gave only racemic products (Scheme 62). Optical rotation measurements 
were used to determine the enantioselectivity of the products. 
 
  
 
 
 
 
 
 
Scheme 62. Michael addition of cyclopentenone with dimethyl malonate catalyzed by guanidines 202, 
203 and 204. 
           Guanidines 202, 203 and 205 were applied to the epoxidation of chalcone by using sodium 
hypochlorite in toluene.
 
The product was not formed and only the starting material was recovered 
(Scheme 63). 
 
 
 
 
 
                    Scheme 63. Attempts at epoxidation of chalcone catalyzed by guanidines 202, 203, 205. 
Previous studies by Basavaiah and co-workers
29
 showed that borane-mediated reduction of 
phenacyl bromide 98 catalyzed by guanidine 97 (Scheme 5) to generate corresponding alcohol. 
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In order to understand the stability of the guanidine moiety in the presence of BH3.SMe2, Basavaiah and 
co-workers treated guanidine derivatives and BH3•SMe2 in toluene at room temperature for 15 min in a 
ratio of 1:20. The 
13
C NMR spectrum showed that the guanidine moiety remained intact as demonstrated 
by; peaks in the region between δ 70-110 and the presence of a peak at 162.0 ppm, belonging to carbon 
nitrogen double bond were unchanged. However, when the reaction was performed in toluene under 
reflux conditions, they observed the presence of a peak at δ 85.0 ppm and absence of a peak at 162.0 ppm, 
which verifies that a reaction occurred (Scheme 64). 
 
  
 
 
  
Scheme 64. Structure of the actual catalyst 97 in BH3.SMe2 at room temperature or under reflux 
conditions.
29
 
        To improve the enantioselectivity, the bulkier N-phenyl and N-methyl guanidines 205, 206 and 207 
were used in the reduction of phenacyl bromide (Scheme 65). The results indicated that only compound 
207 gave any selectivity, with 8% ee (S-configuration), and all other products were obtained as racemates.   
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Scheme 65. Reduction of phenacyl bromide catalyzed by guanidines 205, 206 and 207. 
Reduction of acetophenone 222 under identical conditions obtained (S)-223b in marginally better 24% ee 
for 212 and 10% ee for 211. Both sets of experiments had to be performed in refluxing toluene as there 
was no observable reduction at room temperature (Scheme 66). It is clear from the reduction of 98 that 
the additional stereocentre at C5 is detrimental to the enantioselectivity of this process, possibly by 
virtue of a “mismatch” with the nature of chirality that is induced by the original stereogenic centre of L-
proline. Additional support for this hypothesis would require synthesis of the anti-stereoisomers of 206 
and 207, which unfortunately are not accessible by the current synthetic method.  
 
 
 
 
 
 
Scheme 66. Reduction of acetophenone catalyzed by guanidines 206 and 207. 
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Research attempts were directed towards converting N-aryl urea 166 into N-heterocyclic carbenes for 
transition metal catalysis. The synthesis of these complexes is the topic of the next section. 
2.8. Synthesis of Metal N-Heterocyclic Carbene Complexes 
There are not many examples of N-heterocyclic carbene complexes with annulated NHC ligands, 
most likely because they are unattainable from the common synthetic routes for these compounds. The 
most common way to synthesize of these compounds is the N-alkylation and amination with aryl halides 
(Scheme 67).
78,79
 
 
 
 
 
                      
 
Scheme 67. N-Alkylation and amination of the appropriate aryl halides.
73,74
 
Synthesis of metal N-heterocyclic carbene complexes was started with reduction of 191 with 
DIBAL-H in THF at ‒78 °C (Scheme 68). The result showed cleavage of the carbon-nitrogen bond 
instead of reduction of carbonyl group.  
 
 
                                                                   
 
 
 
 
Scheme 68. Attempt to make aminal. 
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Interestingly, reduction of compound 166 under identical conditions gave the desired product 
167 in 52% yield (Scheme 69). 
 
 
 
 
 
 
 
 
Scheme 69. Synthesis of aminal 167.  
Oxidation of aminal, followed by addition of a base to the salt is the another way to make N-
heterocyclic carbenes (Scheme 70).
80
     
       
 
                                               
 
                       
 
Scheme 70. Synthesis of N-heterocyclic carbene by oxidation of aminal. 
Iodine, triphenylcarbenium tetrafluoroborate and N- bromosuccinimide have been reported as 
oxidizing agents.
75,81,82
 
Blechert reported the synthesis of the imidazolinium salt 230 by using tritylium tetrafluoroborate 
in the synthesis of ruthenium alkylidene complexes (Scheme 71).
75 
 
 
 
 
55 
 
  
 
 
 
 
 
                                                                 
Scheme 71. Synthesis of imidazolinium salt 230 by using tritylium tetrafluoroborate by Blechert.
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Collins and Fournier synthesized compound 233 by adding iodine and sodium bicarbonate in 
dichloromethane, followed by NH4BF4 addition (Scheme 72).
76
  
 
 
 
 
 
                                                                        
Scheme 72. Synthesis of compound 233 by using iodine and sodium bicarbonate in dichloromethane.
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Buchmeiser indicated another method to oxidize aminals, using N-bromosuccinimide in DME to 
synthesize tetrahydropyrimidin-1-ium bromide 235 (Scheme 73).
77 
 
 
 
 
 
Scheme 73. Synthesis of tetrahydropyrimidin-1-ium bromide by using NBS.
77
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Oxidation of aminal 167 by employing iodine and sodium bicarbonate was not successful and starting 
material was recovered (Scheme 74). 
 
 
 
 
Scheme 74. Attempt of salt formation by using iodine. 
We attempted to hydrolyze aminals in order to determine the best method for the salt formation 
(Scheme 75). The synthesis of N-heterocyclic carbenes via hydrolyzing the aminal, followed by addition 
of triethyl orthoformate and ammonium tetrafluoroborate, failed in the first step. The aminal 167 was then 
screened with different acids in ethylene glycol under reflux, such as sulfuric acid and p-toluenesulfonic 
acid. However, the desired product was never made (Scheme 76).  
 
 
                                        
                                             
 
Scheme 75. Hydrolysis of aminal by using acid. 
 
 
 
                                                                           
 
 
Scheme 76. Attempts to hydrolyze aminal by using different acids. 
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Imidazolinium salts 168 and 238 were generated by reaction of N-bromosuccinimide with aminal 
166 in 1,2-dimethoxyethane (DME) followed by anion exchange with sodium tetraphenylborate in 
methanol in overall 73% yield (Scheme 77). Although this reaction gave good crude yield, it was not 
possible to purify the bromine salt.  
 
 
                                                                             
 
 
 
 
 
 
Scheme 77. Synthesis of compound 168 and 238 by employing NBS.  
The synthesis of pure 168 with triphenylcarbenium tetrafluoroborate in dichloromethane was performed 
in 63% yield (Scheme 78).  
 
 
 
                                                                            
                         
Scheme 78. Salt formation by using triphenylcarbenium tetrafluoroborate. 
2.9. Synthesis of NHC complexes 
 
As mentioned earlier in the Introduction in section 1.3, N-heterocyclic carbenes are generated by 
using a base. The appropriate choice of bases depends on the relative strength of the acid.  
Several bases were applied in the synthesis of  N-heterocyclic carbenes, such as t-BuOK, 
KHMDS, NaH, KOC(CH 3)2CH2CH3 and organolithium species (such as n-BuLi, s-BuLi, t-BuLi or LDA) 
(Scheme 79).  
58 
 
 
 
 
 
 
 
bases = KOC(CH 3)2CH2CH3,  
              NaH, KHMDS, t-BuOK 
              organolithium species 
 
 
 
                                              Scheme 79. Synthesis of N-heterocyclic carbenes.  
Compound 168 was treated with t-BuOK, the most common base in N-heterocyclic carbene formation, 
followed by addition of [Rh(COD)Cl]2. The result showed that no N-heterocyclic carbene was formed (t-
BuOK, pKa of the conjugate acid is around 17) (Scheme 80). When the imidazolinium salt 168 was 
treated with potassium bis(trimethylsilyl)amide (pKa of the conjugate acid is around 26), only the starting 
material was recovered. Probably, KHMDS is not strong enough to deprotonate the salt 168. Attempts at 
deprotonation of 168 with organolithium species (pKa of conjugate acid is ≤ 36), resulted in 
decomposition of the starting material.  
 
 
 
 
 
 
 
 
bases = KOC(CH 3)2CH2CH3,  
              , KHMDS, t-BuOK 
              organolithium species 
 
 
Scheme 80. Attempts to prepare complex by using different bases. 
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Another attempt to formation of N-heterocyclic carbene via using lithium bases failed, when 
lithium species were used after formation of chloroimidazolinium salt intermediate by using phosphoryl 
chloride (Scheme 81). 
 
 
 
 
 
 
 
 
 
 
 
 
                                                              
 
 
 
  
 
                  
Scheme 81. Attempts to make carbene complex via chloroimidazolinium.  
Generation of N-heterocyclic carbenes with sodium hydride (pKa of conjugate acid is around 
37) was successful. Thiourea 241 was obtained via successful generation of an N-heterocyclic 
carbene intermediate, followed by addition of S8 in THF (Scheme 82).  
 
 
 
 
                                                                
                     Scheme 82. Synthesis of thiourea via generation of an N-heterocyclic carbene.  
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Complex 240 was formed by addition of sodium hydride to a mixture of salt 168 and 
[Rh(COD)Cl]2 in THF. The result show that the desired chiral Rh–NHC complex as a mixture of 
coordination isomers in 58 % yield (Scheme 83).  
 
 
 
 
 
 
 
 
 
                                                                       
Scheme 83. Synthesis of complex 240 by using sodium hydride. 
However, synthesis of a ruthenium N-heterocyclic carbene complex failed under this reaction 
condition maybe due to steric hindrance between substituents of NHC ligands and the alkylidene 
group or chloride of the ruthenium catalyst. The steric hindrance between adjacent groups can also lead 
to decrease of stability of the pentacoordinate NHC-Ru complexes (Scheme 84). 
 
 
 
 
 
 
 
Scheme 84. Attempt to make ruthenium N-heterocyclic carbene complex. 
Rh-NHC carbonyl complex 242 was synthesized in 78% yield as mixture of isomers in a roughly 
10:1 ratio, by bubbling CO through a solution of 240 in methylene chloride for 3 h and stirring for 16 h 
under CO atmosphere (Scheme 85). 
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Scheme 85. Synthesis of complex 242. 
To establish the feasibility of its use as a catalyst in hydroformylation reactions, complex 242 was 
tested in the hydroformylation of allyl benzene with CO at 20 bar pressure, at 60 °C in the presence of 
triphenylphosphine as a ligand. Reduction with NaBH4 gave the corresponding linear and branched 
alcohols in overall 54% yield in a ratio of 1:2, unfurtunatly no enantioselectivity was observed (Scheme 
86).  
 
 
 
 
Scheme 86. Hydroformylation of allyl benzene catalyzed by complex 242. 
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3. Conclusions and Future Work 
In summary, the N-protection of the imidazolinone 161 was done successfully by using TESCl 
without α-silyl carbanion formation. Different alpha to nitrogen substituted groups such as methyl, 
(diphenylhydroxy)methyl, allyl, silyl and stannyl derivatives were introduced diastereoselectively in syn 
fashion in yields ranging between 47% and 60%.  
In contrast to the previously reported N-t-Bu derivatives, products 181-185 underwent smooth N-
desilylation upon treatment with 2M aqueous HCl for 30 min at room temperature to give secondary ureas 
186-190 in good yields (71-91%).The removal of the N-TES group from the product allowed the 
generation of new N-substituents. Transformation of ureas into guanidines and complexes was done by 
generation of imidazolinium salts via two different pathways and reagents. A number of 
Chloroimidazolinium salts were formed by using excess amounts of neat phosphoryl chloride and 
employed for guanidine formation. On the other hand, an imidazolinium salt was generated by reduction 
of urea by DIBAL-H, followed by oxidation by triphenylcarbenium tetrafluoroborate and finally, 
formation of N-heterocyclic carbene by employing sodium hydride to generate N-heterocyclic carbene 
complex. 
Guanidines 206 and 207 were applied in borane-mediated asymmetric reduction of phenacyl 
bromide. A previous study by Basavaiah showed that S-configured alcohol product 99 in 83% ee.
30
 
Attempts to improve enantioselectivity of this reaction by using bulkier guanidines 207 gave 8% ee with 
S-configuration or as a racemate using 203. Reduction of acetophenone under this conditions gave (S)-
220 in marginally better 24% ee for 207 and 10% for catalyst 206. It is obvious from the reduction of 
phenacyl bromide that the additional stereocentre at C5 is detrimental to the enantioselectivity of this 
process. Higher selectivity probably could be achieved using anti-stereoisomers, which unfortunately are 
not accessible by this methodology. 
The imidazolinium salt underwent complex formation by using sodium hydride at ‒78 °C to room 
temperature. This reaction gave a mixture of coordination isomers, after that Rh-NHC carbonyl complex 
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242 was synthesized smoothly by bubbling CO through a solution of 240 in methylene chloride, but NMR 
techniques showed presence of mixtre of isomers. No enantioselectivity was observed when complex 242 
was applied to hydroformylation of allylbenzene.  
Future work will consider two different areas-modification of the ligand structure, and use of 
these ligands in different catalytic reactions, such as conjugate additions, hydrogenation or 
hydroformylation.  
Further modifications on the ligand may include variation of the phenyl substituents, such as 
phosphorus derivatives with various electronic and steric properties. These properties can have direct 
effects on asymmetric induction in many catalytic organic reactions.  
Although complex 242 did not give enantioselectivity in hydroformylation, this problem may be 
addressed by demanding synthesis of bidentate ligands, including phosphine as reported by Helmchen.
62
  
Product 246 can be prepared by lithiation of 166 followed by diphenylphosphine chloride quench 
to generate 196, and then compound 196 can be protected by an appropriate protecting group such as 
borane to give compound 243. Compound 243 may be reduced by DIBAL-H to generate 244, which may 
convert to imidazolinium salt 245 after treatment with oxidizing agent. Subsequent deprotection of 
phosphorus, followed by N-heterocyclic carbene complex formation in presence of appropriate complex 
would provide 246 (Scheme 87).  
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Scheme 87. Proposed synthetic route for a chiral bidentate complex 246.  
 
 
 
 
 
 
 
 
 
 
 
65 
 
4. Experimental 
 
General. All reagents were purchased from commercial sources and used as received unless otherwise 
indicated. Tetrahydrofuran (THF) was freshly dried and distilled over sodium/benzophenone ketyl under 
an atmosphere of nitrogen. Diethyl ether was distilled over LiAlH4 and stored under an argon atmosphere. 
All alkyllithium bases were titrated against N-benzylbenzamide to a blue endpoint. All reactions were 
performed under argon in flame- or oven-dried glassware using syringe-septum cap techniques unless 
otherwise indicated. Column chromatography was performed on silica gel 60 (70-230 mesh). NMR 
spectra were obtained on a Bruker Avance 300 or 600 MHz instrument and are referenced to TMS or to 
the residual proton signal of the deuterated solvent for 
1
H spectra, and to the carbon multiplet of the 
deuterated solvent for 
13
C spectra according to known values. Enantiomeric ratios were determined on an 
Agilent 1100 series HPLC system at λ = 254 nm using a Chiralcel OD-H column, and were compared 
against racemic material. FT-IR spectra were obtained on an ATI Mattson Research Series spectrometer 
as KBr pellets for solids or on KBr discs for liquids. Optical rotations were measured on a Rudolph 
Research Autopol III automatic polarimeter. Mass spectra were obtained on an MSI/Kratos Concept 1S 
Mass Spectrometer. Melting points were determined on a Kofler hot-stage apparatus on recrystallized 
material unless otherwise indicated, and are uncorrected. 
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(–)-(S)-Tetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-one (161).  
A solution of L-proline hydantoin 173 (3.00 g, 0.02 mol) in THF (130 mL) was                        
transferred by cannula into a stirred suspension of lithium aluminum hydride (2.45 g, 0.06 
mol) in THF (130 mL) at 0 °C, and the mixture was thereafter allowed to stir at room 
temperature for 16 h. After cooling to 0 °C in an ice-water bath, workup was performed by sequential 
addition of water (2.5 mL), 15% aqueous NaOH solution (2.5 mL), and after 15 min, additional water (2.5 
mL). The crude mixture containing aluminum salts was passed through a pad of Celite, rinsing with 
CH2Cl2. The organic phase was separated, dried over anhyd. Na2SO4, filtered, and concentrated under 
reduced pressure. Column chromatography (silica gel, 95:5 CH2Cl2:MeOH, Rf = 0.33) gave 161 as a 
colorless solid that was recrystallized from CH2Cl2 (1.52 g, 56%); mp 178-180 °C (CH2Cl2); [α]D
20
 –102.0 
(c 0.50, CHCl3); IR (KBr) νmax 3264, 2955, 2886, 1693, 1481, 1433, 1404, 1313, 1260, 1193, 1091 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 5.47 (b, 1H), 3.78-3.71 (m, 1H), 3.65-3.53 (m, 2H) 3.32 (dd, 1H, J = 8.9, 
2.4 Hz) 3.06-2.98 (m, 1H), 2.00-1.87 (m, 2H), 1.84-1.72 (m, 1H), 1.49-1.36 (m, 1H); 
13
C NMR (75.5 
MHz, CDCl3) δ 166.3, 59.4, 45.0, 42.9, 30.3, 25.1; EIMS [m/z(%)] 126 (M
+
, 7), 98 (67), 70 (35), 55 
(100), 41 (34); HRMS (EI) calcd for C6H10N2O: 126.0793; found: 126.0794. 
 
(–)-(S)-2-(Trimethylsilyl)tetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-one (177).  
A solution of 161 (500 mg, 3.96 mmol) and TMEDA (0.71 mL, 4.75 mmol) in THF 
(20 mL) at 0 °C was treated with i-PrLi (6.10 mL, 0.8 M, 4.75 mmol), which was 
added dropwise over 15 min. After stirring for an additional 15 min, TMSCl (0.76 
mL, 5.90 mmol) was added and the mixture was allowed to stir at room temperature for 16 h. The 
reaction mixture was cooled in an ice-water bath, worked up by addition of water (20 mL), and extracted 
with CH2Cl2 (4 × 20 mL). The combined organic phase was dried over anhyd. Na2SO4, filtered and 
concentrated under reduced pressure. The crude product was purified by flash column chromatography 
(silica gel, 7:3 hexane:EtOAc, Rf = 0.28) to give 174 as a colorless oil (310 mg, 46%); [α]D
20
 –53.7 (c 
1.00, CHCl3); IR (KBr, neat) νmax 2953, 1681, 1481, 1460, 1392, 1318, 1249, 1162 cm
-1
; 
1
H NMR (300 
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MHz, CDCl3) δ 3.54-3.22 (m, 3H), 3.20 (dd, 1H, J = 7.8, 1.5 Hz), 3.03-2.95 (m, 1H), 1.94-1.75 (m, 3H), 
1.33-1.26 (m, 1H), 0.24 (s, 9H); 
13
C NMR (75.5 MHz, CDCl3) δ 167.5, 59.1, 45.8, 45.3, 30.6, 25.0, –1.2; 
EIMS [m/z(%)] 198 (M
+
, 8), 183 (100), 100 (29), 55 (62), HRMS (EI) calcd for C9H18N2OSi: 198.1188; 
found:198.1190. 
 
(–)-(S)-2-((Bis(trimethylsilyl)methyl)dimethylsilyl)tetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-one 
(175).  
 A solution of 174 (40 mg, 0.32 mmol) and TMEDA (0.10 mL, 0.67 mmol) in 
THF (4 mL) at –78 °C was treated with i-PrLi (0.60 mL, 1.1 M, 0.67 mmol). 
After 2 h, the reaction mixture was quenched with TMSCl (0.09 mL, 0.67 mmol) 
and, after 15 min, was stirred at room temperature for 16 h. After cooling in an ice-water bath, the 
reaction mixture was worked up by addition of water (7 mL) and extracted with CH2Cl2 (4 × 7 mL). The 
combined organic phase was dried over anhyd. Na2SO4, filtered and concentrated under reduced pressure. 
The crude product was purified by flash column chromatography (silica gel, 7:3 hexane:EtOAc, Rf = 
0.66) to give 175 as a colorless glass (29 mg, 26%); [α]D
20
 –26.9 (c 0.27, CHCl3); IR (KBr) νmax 2955, 
1675, 1481, 1397, 1319, 1256, 1010 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 3.69-3.53 (m, 3H), 3.21 (dd, 1H, 
J = 7.8, 1.6 Hz), 3.03-2.94 (m, 1H), 1.96-1.83 (m, 2H), 1.82-1.71 (m, 1H), 1.36-1.23 (m, 2H), 0.25 (d, 
6H, J = 3.7 Hz), 0.1 (s, 18H); 
13
C NMR (75.5 MHz, CDCl3) δ 167.5, 58.8, 46.1, 45.4, 30.8, 25.0, 2.9, 2.3, 
1.7; EIMS [m/z(%)] 342 (M
+
, 88), 217 (62), 129 (73), 73 (100); HRMS (EI) calcd for C15H34N2OSi3: 
342.1979; found: 342.1978. 
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(–)-(S)-2-(Triethylsilyl)tetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-one (162).                             
A solution of 161 (800 mg, 6.34 mmol) and TMEDA (1.13 mL, 7.60 mmol) in THF 
(35 mL) at 0 °C was treated with i-PrLi (5.85 mL, 1.3 M, 7.60 mmol), added 
dropwise over 15 min. After stirring for an additional 15 min, chlorotriethylsilane 
(1.60 mL, 9.51 mmol) was added and the mixture was allowed to stir at room temperature for 16 h. The 
reaction mixture was cooled in an ice-water bath, worked up by addition of water, and extracted with 
CH2Cl2 (4 × 30 mL). The combined organic phase was dried over anhyd. Na2SO4, filtered and 
concentrated under reduced pressure. The product was purified by flash column chromatography (silica 
gel, 7:3 hexane:EtOAc, Rf = 0.54) to give 162 as a colorless oil (1.17 g, 77%); [α]D
20
 –46.2 (c 0.10, 
CHCl3); IR (KBr, neat) νmax 2953, 1681, 1481, 1460, 1392, 1318, 1249, 1162, 1007 cm
-1
; 
1
H NMR (300 
MHz, CDCl3) δ 3.74-3.59 (m, 3H), 3.25 (d, 1H, J = 7.8 Hz), 3.05-2.97 (m, 1H), 2.00-1.86 (m, 2H), 1.83-
1.73 (m, 1H), 1.40-1.26 (m, 1H), 0.96 (t, 9H, J = 7.1 Hz), 0.77 (q, 6H, J = 7.1 Hz); 
13
C NMR (75.5 MHz, 
CDCl3) δ 167.9, 59.2, 46.4, 45.5, 30.6, 25.0, 6.9, 3.4; EIMS [m/z(%)] 240 (M
+
, 7), 211 (100), 100 (11); 
HRMS (EI) calcd for C12H24N2Si: 240.1658; found: 240.1661.  
 
 
(–)-(5S,7aS)-5-Methyl-2-(triethylsilyl)tetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-one (181).  
A solution of 162 (500 mg, 2.08 mmol) and TMEDA (0.37 mL, 2.50 mmol) in Et2O 
(30 mL) at –78 °C was treated with i-PrLi (1.92 mL, 1.30 M, 2.50 mmol). After 2 h, 
Me2SO4 (0.40 mL, 3.12 mmol) was added and the reaction mixture was allowed to 
warm up slowly to room temperature. The reaction mixture was cooled in an ice-water bath, worked up 
with water (10 mL), and extracted with CH2Cl2 (4 × 10 mL). The combined organic phase was dried over 
anhyd. Na2SO4, filtered and concentrated under reduced pressure. Flash column chromatography (silica 
gel, 7:3 hexane:EtOAc, Rf = 0.32) gave 181 as a colorless oil (315 mg, 60%); [α]D
20 –24.4 (c 1.01, 
CHCl3); IR (KBr, neat) νmax 2954, 2875, 1678, 1460, 1400, 1266, 1132, 1006 cm
-1
; 
1
H NMR (300 MHz, 
CDCl3) δ 4.01-3.96 (m, 1H), 3.69-3.57 (m, 1H), 3.49 (t, 1H, J = 8.9 Hz), 3.12 (dd, 1H, J = 7.1, 2.5 Hz), 
2.16-2.13 (m, 1H), 1.92-1.81 (m, 1H), 1.75-1.70 (m, 1H), 1.62-1.49 (m, 1H), 1.39 (d, 3H, J = 6.4 Hz), 
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0.98 (t, 9H, J = 7.5 Hz), 0.82-0.75 (m, 6H); 
13
C NMR (75.5 MHz, CDCl3) δ 163.9, 56.4, 46.3, 45.9, 38.5, 
30.7, 24.9, 12.7, –2.5; EIMS [m/z(%)] 254 (M+, 7), 25 (100), 211 (11), 100 (7); HRMS (EI) calcd for 
C13H26N2OSi: 254.1814; found: 254.1821.  
 
(+)-(5R,7aS)-5-(Hydroxydiphenylmethyl)-2-(triethylsilyl)tetrahydro-1H-pyrrolo[1,2-c]imidazol-
3(2H)-one (182).   
A solution of 162 (500 mg, 2.08 mmol) and TMEDA (0.37 mL, 2.50 mmol) 
in Et2O (30 mL) at –78 °C was treated with i-PrLi (1.56 mL, 1.6 M, 2.50 
mmol). After 2 h, a solution of benzophenone (568 mg, 3.12 mmol) in THF 
(5 mL) was added slowly by cannula, and the reaction mixture was allowed to warm slowly to room 
temperature. The reaction mixture was cooled in an ice-water bath, worked up with water (10 mL) and 
extracted with CH2Cl2 (4 × 10 mL). The combined organic phase was dried over anhyd. Na2SO4, filtered 
and concentrated under reduced pressure. Flash column chromatography (silica gel, 9:1 hexane:EtOAc, Rf 
= 0.62) gave 182 as a colourless oil (495 mg, 56%); [α]D
20
 +153.0 (c 1.10, CHCl3); IR (KBr, neat) νmax 
3206, 2954, 1647, 1414, 1262, 1145, 1006, 636, 600 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 7.64 (d, 2H, J = 
7.5 Hz), 7.45 (d, 2H, J = 7.5 Hz), 7.34-7.16 (m, 6H), 4.32-4.26 (m, 1H), 3.90-3.85 (m, 1H), 3.63 (t, 1H, J 
= 7.5 Hz), 3.20 (dd, 1H, J = 7.6, 3.1 Hz), 2.17-2.04 (m, 1H), 1.97-1.83 (m, 1H), 1.58-1.45 (m, 1H), 1.42-
1.30 (m, 2H), 0.94 (t, 9H, J = 7.5 Hz), 0.80-0.72 (m, 6H); 
13
C NMR (75.5 MHz, CDCl3) δ 166.0, 147.7, 
146.3, 128.2, 127.8, 127.7, 126.4, 126.3, 126.0, 76.8, 66.9, 60.7, 47.8, 29.2, 25.9, 6.8, 3.3; EIMS [m/z(%)] 
422 (M
+
, 21), 239 (25), 182 (53), 105 (92), 77 (100), 51 (64); HRMS (EI) calcd for C25H34N2O2Si: 
422.2390; found: 422.2384.  
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(+)-(5R,7aS)-5-Allyl-2-(triethylsilyl)tetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-one (183).  
A solution of 162 (1.00 mg, 4.16 mmol) and TMEDA (0.74 mL, 5.00 mmol) in 
THF (30 mL) at –78 °C was treated with i-PrLi (3.84 mL, 1.3 M, 5.00 mmol). 
After 2 h, a solution of CuCN (185 mg, 2.08 mmol) and LiCl (176 mg, 4.16 
mmol) in THF (5 mL) was added slowly by cannula, and stirring was continued at –78 °C. After 1 h, allyl 
bromide (0.43 mL, 4.50 mmol) was added and the reaction mixture was allowed to warm up slowly to 
room temperature. The reaction mixture was cooled in an ice-water bath, worked up with water (30 mL) 
and extracted with CH2Cl2 (4 × 30 mL). The combined organic extract was dried over anhyd. Na2SO4, 
filtered and concentrated under reduced pressure. Flash column chromatography (silica gel, 7:3 
hexane:EtOAc, Rf = 0.33) gave 183 as a colorless oil (518 mg, 47%); [α]D
20
 +10.2 (c 0.75, CHCl3); IR 
(KBr, neat) νmax 2955, 1687, 1460, 1393, 1251, 1124, 1005 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 5.86-5.73 
(m, 1H), 5.15-5.04 (m, 2H), 4.04-3.93 (m, 1H) 3.60-3.50 (m, 2H) 3.18 (dd, 1H, J = 7.4, 2.1 Hz), 3.04-
2.96 (m, 1H), 2.44-2.33 (m, 1H), 2.14-2.00 (m, 1H), 1.94-1.85 (m, 2H), 1.56-1.45 (m, 1H), 0.98 (t, 9H, J 
= 7.5 Hz), 0.82-0.77 (m, 6H); 
13
C NMR (75.5 MHz, CDCl3); δ 163.0, 135.5, 117.1, 60.6, 56.0, 48.9, 35.2, 
32.5, 29.9, 6.9, 3.5; EIMS [m/z(%)] 280 (M
+
, 4), 251 (30), 239 (100), 115 (36), 87 (53), 59 (35); HRMS 
(EI) calcd for C15H28N2OSi: 280.1971; found: 280.1974. 
 
(–)-(5S,7aS)-2-(Triethylsilyl)-5-(trimethylsilyl)tetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-one 
(184).                                         
A solution of 162 (800 mg, 3.33 mmol) and TMEDA (0.60 mL, 4.00 mmol) in 
Et2O (32 mL) at –78 °C was treated with i-PrLi (2.50 mL, 1.60 M, 4.00 mmol). 
After 2 h, TMSCl (0.64 mL, 5.00 mmol) was added and the reaction mixture was 
allowed to warm up slowly to room temperature. The reaction mixture was cooled in an ice-water bath 
and worked up by addition of water (30 mL). After separation of the layers, the aqueous phase was 
extracted with CH2Cl2 (4 × 30 mL), and the combined organic extract was dried over anhyd Na2SO4, 
filtered and concentrated under reduced pressure. The product was purified by flash column 
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chromatography (silica gel, 9:1 hexane:EtOAc, Rf = 0.54) to give 184 as a colorless oil (893 mg, 86%); 
[α]D
20
 –45.1 (c 0.59, CHCl3); IR (KBr, neat) νmax 2953, 1689, 1461, 1399, 1251, 1134, 1005 cm
-1
; 
1
H 
NMR (600 MHz, CDCl3) δ 3.74-3.70 (m, 1H), 3.61 (t, 1H, J = 9.0 Hz), 3.18 (d, 1H, J = 9.6 Hz), 2.46 (t, 
1H, J = 8.7 Hz), 2.02-1.97 (m, 1H), 1.92-1.86 (m, 1H), 1.71-1.66 (m, 1H), 1.49-1.45 (m, 1H), 0.96 (t, 9H, 
J = 7.8 Hz), 0.84-0.76 (m, 6H), 0.19 (s, 9H); 
13
C NMR (150.9 MHz, CDCl3) δ 166.1, 60.5, 49.7, 47.7, 
31.6, 27.9, 6.8, 3.4, –1.0; EIMS [m/z(%)] 312 (M+, 12), 297 (100), 283 (70), 239 (58), 87 (36), 73 (32) , 
59 (40); HRMS (EI) calcd for C15H32N2OSi2: 312.2053; found: 312.2045.  
 
(–)-(5S,7aS)-2-(Tributylstannyl)-5-(trimethylsilyl)tetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-one 
(185).   
A solution of 162 (207 mg, 0.86 mmol) and TMEDA (0.15 mL, 1.03 mmol) 
in Et2O (10 mL) at –78 °C was treated with i-PrLi (0.65 mL, 1.6 M, 1.03 
mmol). After 2 h, Bu3SnCl (0.35 mL, 1.29 mmol) was added, and the reaction 
mixture was allowed to warm up slowly to room temperature. The reaction mixture was cooled in an ice-
water bath, worked up with water (10 mL) and extracted with Et2O (4 × 10 mL). The combined organic 
extract was dried over anhyd. Na2SO4, filtered and concentrated under reduced pressure. Flash column 
chromatography (silica gel, 7:3 hexane:EtOAc, Rf = 0.92) gave 185 as a colorless oil (358 mg, 60%); 
[α]D
20
 –17.8 (c 0.59, CHCl3); IR (KBr, neat) νmax 2954, 1674, 1462, 1401, 1257, 1204, 1123, 1005 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 3.69-3.63 (m, 1H), 3.59 (t, 1H, J = 9.0 Hz), 3.18 (dd, 1H, J = 7.4, 1.6 Hz), 
2.69 (t, 1H, J = 8.3 Hz), 2.07-1.92 (m, 2H), 1.83-1.73 (m, 1H), 1.58-1.46 (m, 6H), 1.39-1.26 (m, 7H), 
0.99-0.74 (m, 24H), 0.81-0.74 (m, 6H); 
13
C NMR (75.5 MHz, CDCl3) δ 167.5, 59.7, 46.6, 44.9, 31.6, 
29.7, 29.3, 27.6, 13.8, 11.4, 6.8, 3.4; EIMS [m/z(%)] 473 (M-C4H9, 71), 239 (32), 209 (69), 41 (100); 
HRMS (EI) calcd for C20H41N2OSiSn: 473.2010; found: 473.2006.  
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(–)-(5S,7aS)-5-Methyltetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-one (186).  
A solution of 181 (333 mg, 1.32 mmol) in MeOH (1.3 mL) was treated with 2 M 
aq. HCl (8 mL). The mixture was stirred at room temperature for 30 min and 
worked up by careful addition of a saturated solution of aqueous NaHCO3 (10 mL). 
The crude mixture was extracted with CH2Cl2 (4 × 10 mL), and the combined organic phase was dried 
over anhyd. Na2SO4, filtered and concentrated under reduced pressure. Flash column chromatography 
(silica gel, 7:3 hexane:EtOAc, Rf = 0.10) gave 186 as a colorless solid (155 mg, 84%) that was 
recrystallized from EtOAc/hexane; mp 65-67 °C (EtOAc/hexane); [α]D
20
 –20.9 (c 1.00, CHCl3); IR (KBr, 
neat) νmax 3298, 2968, 1697, 1487, 1440, 1271, 1155, 1125, 1093 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 
4.77 (b, 1H), 4.13-4.03 (m, 1H), 3.74-3.68 (m, 1H), 3.58 (t, 1H, J = 8.5 Hz), 3.24 (t, 1H, J = 8.2 Hz), 
2.26-2.13 (m, 1H), 2.01-1.92 (m, 1H), 1.79-1.69 (m, 1H), 1.67-1.56 (m, 1H), 1.43 (d, 3H, J = 6.8 Hz); 
13
C 
NMR (75.5 MHz, CDCl3) δ 162.0, 60.9, 51.8, 46.0, 35.8, 29.5, 18.3; EIMS [m/z(%)] 140 (M
+
, 26), 125 
(100), 69 (71). HRMS (EI) calcd for C7H12N2O: 140.0950; found: 140.0947.  
 
(+)-(5R,7aS)-5-(Hydroxydiphenylmethyl)tetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-one (187).  
  A solution of 182 (100 mg, 0.24 mmol) in MeOH (1 mL) was treated with 2 M 
aq. HCl (4 mL). The mixturewas stirred at room temperature for 30 min and 
worked up by careful addition of a saturated solution of aqueous NaHCO3 (10 
mL). The crude mixture was extracted with CH2Cl2 (4 × 7 mL), and the combined organic phase was 
dried over anhyd. Na2SO4, filtered and concentrated under reduced pressure. Flash column 
chromatography (silica gel, 7:3 hexane:EtOAc, Rf = 0.19) gave 187 as a colorless oil (58 mg, 80%); [α]D
20
 
+146.0 (c 0.65 , CHCl3); IR (KBr, neat) νmax 3206, 2955, 1668, 1487, 1448, 1416, 1266, 1150, 1005 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 7.66 (d, 2H, J = 7.5 Hz), 7.47 (d, 2H, J = 7.5 Hz), 7.34-7.17 (m, 6H), 5.34 
(b, 1H), 4.30-4.24 (m, 1H), 3.95-3.92 (m, 1H), 3.56 (t, 1H, J = 8.4 Hz), 3.20 (dd, 1H, J = 8.4, 1.8 Hz), 
2.17-2.03 (m, 2H), 2.00-1.88 (m, 1H), 1.66-1.60 (m, 1H), 1.36-1.29 (m, 1H); 
13
C NMR (75.5 MHz, 
CDCl3) δ 163.6, 147.5, 145.9, 127.9, 127.8, 126.6, 126.5, 126.4, 125.8, 77.2, 66.6, 60.6, 44.0, 28.9, 25.7; 
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EIMS [m/z(%)] 308 (M
+
, 17), 182 (44), 125 (68) 105 (100), 77 (40); HRMS (EI) calcd for C19H20N2O2: 
308.1525; found: 308.1529.  
 
(–)-(5R,7aS)-5-Allyltetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-one (188).  
A solution of 183 (238 mg, 0.89 mmol) in MeOH (1.2 mL) was treated with 2 M 
aq. HCl (6 mL). The mixture was stirred at room temperature for 30 min and 
worked up by careful addition of a saturated solution of aqueous NaHCO3 (10 
mL). The crude mixture was extracted with CH2Cl2 (4 × 10 mL), and the combined organic phase was 
dried over anhyd. Na2SO4, filtered and concentrated under reduced pressure. Flash column 
chromatography (silica gel, 7:3 hexane:EtOAc, Rf = 0.11) gave 188 as a colorless oil (111 mg, 82%); 
[α]D
20
 –5.3 (c 1.01, CHCl3); IR (KBr) νmax 3229 , 2968, 1682, 1490, 1451, 1404, 1281, 1145, 1004 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 5.84-5.72 (m, 1H), 5.18-5.04 (m, 2H), 4.13-4.02 (m, 2H), 3.63-3.54 (m, 
2H), 3.23 (t, 1H, J = 8.0 Hz), 3.08-3-3.00 (m, 1H), 2.36-2.26 (m, 1H), 2.16-2.03 (m, 1H), 1.97-1.90 (m, 
2H), 1.65-1.52 (m, 1H); 
13
C NMR (75.5 MHz, CDCl3) δ 161.4, 135.3, 117.4, 60.8, 55.4, 46.1, 35.4, 32.4, 
29.3; EIMS [m/z(%)] 166 (M
+
, 3), 125 (100); HRMS (EI) calcd for C9H14N2O: 166.1106; found: 
166.1105.  
 
 
(–)-(5S,7aS)-5-(Trimethylsilyl)tetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-one (189).   
 
 A solution of 184 (413 mg, 1.32 mmol) in MeOH (1.8 mL) was treated with 2 M 
aq. HCl (10 mL). The mixture was stirred at room temperature for 30 min and 
worked up by careful addition of a saturated solution of aqueous NaHCO3 (10 
mL). The crude mixture was extracted with CH2Cl2 (4 × 10 mL), and the combined organic phase was 
dried over anhyd. Na2SO4, filtered and concentrated under reduced pressure. Flash column 
chromatography (silica gel, 7:3 hexane:EtOAc, Rf = 0.13) gave 189 as a colorless solid (238 mg, 91%) 
that was recrystallized from EtOAc/hexane; mp 100-103 °C (EtOAc/hexane); [α]D
20
 –67.1 (c 0.52, 
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CHCl3); IR (KBr) νmax 3259, 2948, 1682, 1490, 1446, 1411, 1272, 1243, 1126 cm
-1
; 
1
H NMR (300 MHz, 
CDCl3) δ 4.40 (b, 1H), 3.92-3.81 (m, 1H), 3.65 (t, 1H, J = 8.5 Hz), 3.26 (dd, 1H, J = 8.7, 3.4 Hz), 2.47 
(dd, 1H, J = 7.8, 2.4 Hz), 2.12-1.88 (m, 2H), 1.79-1.52 (m, 2H), 0.18 (s, 9H); 
13
C NMR (75.5 MHz, 
CDCl3) δ 164.1, 60.6, 49.2, 44.0, 31.2, 27.9, –1.1; EIMS [m/z(%)] 199 (M
+
, 37) 183 (100), 73 (36); 
HRMS (FAB) calcd for C9H18N2OSi: 199.1267; found: 199.1266.  
 
(–)-(5S,7aS)-5-(Tributylstannyl)tetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-one (190).  
 A solution of 185 (240 mg, 0.58 mmol) in MeOH (1 mL) was treated with 2 M 
aq. HCl (8 mL). The mixture was stirred at room temperature for 30 min and 
worked up by careful addition of a saturated solution of aqueous NaHCO3 (10 
mL). The crude mixture was extracted with CH2Cl2 (4 × 10 mL), and the combined organic phase was 
dried over anhyd. Na2SO4, filtered and concentrated under reduced pressure. Flash column 
chromatography (silica gel, 7:3 hexane:EtOAc, Rf = 0.17) gave 190 as a colorless oil (141 mg, 71%); 
[α]D
20
 –16.5 (c 0.40, CHCl3); IR (KBr, neat) νmax 3229, 2954, 1692, 1453, 1265, 1072 cm
-1
; 
1
H NMR (300 
MHz, CDCl3) δ 4.47 (b, 1H), 3.82-3.75 (m, 1H), 3.63 (t, 1H, J = 8.0 Hz), 3.24 (dd, 1H, J = 8.7, 2.4 Hz), 
2.67 (t, 1H, J = 8.5 Hz), 2.07-1.98 (m, 2H), 1.84-1.74 (m, 1H), 1.55-1.47 (m, 6H), 1.36-1.29 (m, 7H), 
0.93-0.88 (m, 15H); 
13
C NMR (75.5 MHz, CDCl3) δ 165.8, 59.7, 44.4, 43.3, 31.5, 29.7, 29.3, 27.3, 13.8, 
11.2; EIMS [m/z(%)] 359 (M‒C4H9, 68), 125 (73), 68 (56), 41 (100); HRMS (EI) calcd for C14H27N2OSn: 
359.1145; found: 359.1149.  
 
(5S,7aS)-2-Methyl-5-(trimethylsilyl)tetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-one (191).                                     
A solution of 189 (270 mg, 1.36 mmol) in DMF (5 mL) at 0 °C was transferred by 
cannula into a stirred suspension of sodium hydride (131 mg, 5.46 mmol) in DMF 
(5 mL) at 0 °C. After 45 min iodomethane (0.24 mL, 3.82 mmol) was added into 
mixture at 0 °C, the mixture was thereafter allowed to stir to at room temperature for 16 h. After cooling 
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to 0 °C in an ice-water bath, workup was performed by sequential addition of NH4Cl (20 mL) and water 
(80 mL), and the mixture was extracted with CH2Cl2 (4 × 10 mL). The combined organic phase was dried 
over anhyd. Na2SO4, filtered and concentrated under reduced pressure. Flash column chromatography 
(silica gel, 7:3 hexane:EtOAc, Rf = 0.51) gave 191 as a colourless oil (171 mg, 60%); [α]D
20
  +10.0 (c 
0.75, CHCl3); IR (KBr) νmax 2955, 1687, 1460, 1393, 1251, 1124, 1005, 961, 740 cm
-1
; 
1
H NMR (300 
MHz, CDCl3): δ 3.69-3.60 (m, 1H), 3.47 (t, 1H), 3.18 (dd, 1H, J = 6.7, 2.5 Hz), 2.76 (s, 3H) 2.43 (dd, 1H, 
J  = 7.7, 2.9 Hz), 2.09-1.97 (m, 1H), 1.92-1.81 (m, 1H), 1.71-1.58 (m, 1H), 1.57-1.43 (m, 1H), 0.17 (s, 
9H); 
13
C NMR (75.5 MHz, CDCl3); δ 162.7, 57.4, 50.8, 50.1, 31.4, 31.01, 27.6; EIMS [m/z(%)] 213 (M
+
, 
6.3), 197 (100), 139 (28.2), 73 (25.7) . HRMS (EI) calcd for C10H20N2OSi: 212.1345; found: 212.1349. 
 
(–)-(5S,7aS)-5-Methyl-2-phenyltetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-one (166).                                    
A 2-necked flask under argon was charged with 186 (643 mg, 4.59 mmol), CuI 
(700 mg, 3.67 mmol), TMEDA (0.09 mL, 0.90 mmol), iodobenzene (1.13 mL, 
10.12 mmol), K2CO3 (1671 mg, 12.20 mmol), and toluene (6 mL). The mixture 
was heated to reflux for 24 h, then cooled to room temperature, diluted with CH2Cl2 (50 mL), filtered 
through Celite and washed with additional CH2Cl2 (4 × 30 mL). The organic filtrate was washed with 
H2O (4 × 50 mL), dried over anhyd. Na2SO4, filtered and concentrated under reduced pressure. Flash 
column chromatography (silica gel, 9:1 hexane:EtOAc, Rf = 0.18) gave 166 as a colorless solid (738 mg, 
74%) that was recrystallized from EtOAc/hexane; mp 110-112 °C (EtOAc/hexane); [α]D
20
 –22.5 (c 0.90, 
CHCl3); IR (KBr) νmax 2890, 1943, 1862, 1681, 1598, 1384, 1280, 1153, 1085, 1054 cm
-1
; 
1
H NMR (300 
MHz, CDCl3) δ 7.51-7.48 (m, 2H), 7.36-7.28 (m, 2H), 7.04-6.99 (m, 1H), 4.09-4.01 (m, 1H), 3.91 (t, 1H, 
J = 8.4 Hz), 3.87-3.82 (m, 1H), 3.69 (t, 1H, J = 8.4 Hz), 2.25-2.19 (m, 1H), 2.14-2.07 (m, 1H), 1.86-1.78 
(m, 1H), 1.74-1.64 (m, 1H), 1.44 (d, 3H, J = 6.3 Hz); 
13
C NMR (75.5 MHz, CDCl3) δ 156.7, 140.7, 128.7, 
122.04, 117.3, 56.6, 52.2, 50.7 35.6, 29.9, 18.4; EIMS [m/z(%)] 217 (M
+
, 14), 201 (74), 69 (100), 55 (49); 
HRMS (EI) calcd for C13H16N2O: 216.1263; found: 216.1262. 
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(–)-(5S,7aS)-2-Phenyl-5-(trimethylsilyl)tetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-one (194).                                    
A 2-necked flask under argon was charged with 189 (100 mg, 0.51 mmol), CuI 
(77 mg, 0.40 mmol), TMEDA (0.01 mL, 0.10 mmol), iodobenzene (0.12 mL, 1.10 
mmol), K2CO3 (138 mg, 1.00 mmol), and toluene (1mL). The mixture was heated 
to reflux for 24 h, then cooled to room temperature, diluted with CH2Cl2 (15 mL), filtered through Celite 
and washed with additional CH2Cl2 (4 × 15 mL). The organic filtrate was washed with H2O (4 × 15 mL), 
dried over over anhyd. Na2SO4, filtered and concentrated under reduced pressure. Flash column 
chromatography (silica gel, 9:1 hexane:EtOAc, Rf = 0.41) gave 194 as a colorless solid (56 mg, 40%) that 
was recrystallized from EtOAc/hexane; mp 138-140 °C (EtOAc/hexane); [α]D
20
 –70.1 (c 1.50, CHCl3); IR 
(KBr) νmax 3396, 2917, 1704, 1600, 1502, 1481, 1402, 1317, 1243, 1153, 1128, 1076, 1027 cm
-1
; 
1
H NMR 
(300 MHz, CDCl3) δ 7.57 (dd, 2H, J = 7.8, 1.3 Hz), 7.54-7.39 (m, 2H), 7.03 (t, 1H, J = 7.3 Hz), 4.03-4.00 
(t, 1H, J = 8.9 Hz), 3.88-3.79 (m, 1H), 3.66 (dd, 1H, J = 9.0, 3.3 Hz), 2.56 (dd, 1H, J = 10.2, 7.8 Hz), 
2.19-2.10 (m, 1H), 1.92-1.84 (m, 1H), 1.80-1.71 (m, 1H), 1.64-1.60 (m, 1H), 0.23 (s, 9H); 
13
C NMR (75.5 
MHz, CDCl3) δ 159.2, 140.6, 128.8, 122.4, 117.7, 56.5, 49.8, 48.9, 31.8, 27.9, –0.99; EIMS [m/z(%)] 274 
(M
+
, 11), 259 (81), 183 (76), 73 (100); HRMS (EI) calcd for C15H22N2OSi: 274.1501; found: 274.1491.  
 
(5S,7aS)-2-(2-Iodophenyl)-5-methyltetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-one (195).                                  
A solution of 166 (100 mg, 0.46 mmol) and TMEDA (0.08 mL, 0.55 mmol) in 
THF (4 mL) at –78 °C was treated with i-PrLi (0.44 mL, 1.2 M, 0.55 mmol). 
After 2 h, a solution of 1,2-diiodoethane (197 mg, 0.70 mmol) in THF (2 mL) 
was added slowly by cannula, and the reaction mixture was allowed to warm slowly to room temperature. 
The reaction mixture was cooled in an ice-water bath, worked up with water (10 mL) and extracted with 
CH2Cl2 (4 × 10 mL). The combined organic phase was dried over anhyd. Na2SO4, filtered and 
concentrated under reduced pressure. Flash column chromatography (silica gel, 7:3 hexane:EtOAc, Rf = 
0.23) gave 195 as a colorless solid (106 mg, 67%) that was recrystallized from EtOAc/hexane; mp 144-
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147 °C (EtOAc/hexane); [α]D
20
 –29.5 (c 2.50, CHCl3); IR (KBr) νmax 3072, 2987, 2955, 2887, 2839, 1685, 
1565, 1468, 1440, 1397, 1280, 1103, 1019, 949, 862, 759, 717, 678, cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 
7.86 (dd, 1H, J = 7.2, 1.4 Hz), 7.40-7.34 (m, 1H), 7.30 (dd, 1H, J = 6.5, 1.4 Hz), 7.00 (dd, 1H, J = 6.1, 1.8 
Hz), 4.13-4.05 (m, 1H), 3.85-3.77 (m, 2H), 3.70-3.66 (m, 1H), 2.26-2.14 (m, 1H), 2.08-2.00 (m, 1H), 
1.85-1.71 (m, 2H), 1.50 (d, 3H, J = 6.4 Hz);  
13
C NMR (75.5 MHz, CDCl3) δ 158.1, 141.9, 139.7, 129.3, 
129.1, 128.9, 99.2, 57.9, 52.9, 52.4, 35.4, 29.7, 18.4; HRMS (EI) calcd for C13H15IN2O: 342.0221; found: 
342.0218.   
 
(5S,7aS)-2-(2-(Diphenylphosphino)phenyl)-5-methyltetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-
one (196).  
A solution of 166 (100 mg, 0.46 mmol) and TMEDA (0.08 mL, 0.55 mmol) in 
THF (4 mL) at –78 °C was treated with i-PrLi (0.44 mL, 1.2 M, 0.55 mmol). 
After 2 h, PPh2Cl (0.12 mL, 0.70 mmol) was added, and the reaction mixture 
was allowed to warm up slowly to room temperature. The reaction mixture was cooled in an ice-water 
bath and quenched with a saturated solution of NH4Cl (4 mL), worked up with water (10 mL) and extracted 
with CH2Cl2 (4 × 10 mL). The combined organic extract was dried over anhyd. Na2SO4, filtered and 
concentrated under reduced pressure. Flash column chromatography (silica gel, 7:3 hexane : EtOAc, Rf = 
0.21) gave 196 as a colorless oil (85 mg, 47%); [α]D
20
 +15.9 (c 1.00, CHCl3); IR (KBr, neat) νmax 3054, 
2966, 1691, 1584, 1471, 1435, 1347, 1217, 741, 694, 663, cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 7.83-7.64 
(m, 2H), 7.34-7.32 (m, 10H), 7.20-7.15 (m, 1H), 6.89-6.85 (m, 1H), 3.88-3.80 (m, 1H), 3.70-3.61 (m, 
2H), 3.60 (t, 1H, J = 8.3 Hz), 2.10-1.99 (m, 1H), 1.93-1.85 (m, 1H), 1.56-1.51 (m, 2H), 1.28 (d, 3H, J = 
6.8 Hz);  
13
C NMR (75.5 MHz, CDCl3) δ 158.9, 143.7 (d, J = 20.8 Hz), 137.1 (d, J = 13.6 Hz ), 136.5 (d, 
J = 10.5 Hz), 134.2, 134.1, 134.0, 133.9, 133.7, 130.1, 128.8, 128.5, 128.4, 128.0, 127.4, 57.8, 53.3, 52.8, 
35.1, 29.5, 18.0; HRMS (EI) calcd for C25H25N2OP: 400.1699; found: 400.1701.  
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(5R,7aS)-5-(Hydroxydiphenylmethyl)-2-phenyltetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-one 
(197).                                                
A 2-necked flask under argon was charged with 187 (500 mg, 1.62 mmol), CuI 
(247 mg, 1.30 mmol), TMEDA (0.1 mL, 0.65 mmol), iodobenzene (0.4 mL, 3.56 
mmol), K2CO3 (560 mg, 4.05 mmol), and toluene (3mL). The mixture was heated 
to reflux for 24 h, then cooled to room temperature, diluted with CH2Cl2 (15 mL), filtered through Celite 
and washed with additional CH2Cl2 (4 × 15 mL). The organic filtrate was washed with H2O (4 × 15 mL), 
dried over anhyd. Na2SO4, filtered and concentrated under reduced pressure. Flash column 
chromatography (silica gel, 9:1 hexane:EtOAc, Rf = 0.41) gave 197 as a colorless solid (303 mg, 49%) 
that was recrystallized from EtOAc/hexane; mp 195-198 °C (EtOAc/hexane); [α]D
20
 –153.8 (c 1.15, 
CHCl3); IR (KBr) νmax 3216, 3059, 3024, 2954, 2918, 1655, 1598, 1500, 1451, 1384, 1268, 1170, 965, 
725, 692 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 7.73 (d, 2H, J = 7.8 Hz), 7.51-7.47 (m, 4H), 7.37-7.17 (m, 
8H), 7.07 (t, 1H, J = 7.4 Hz), 4.44-4.40 (dd, 1H, J = 7.1, 1.7 Hz), 4.03-3.37 (m, 3H), 3.67 (dd, 1H, J = 
7.0, 2.0 Hz), 2.30-2.16 (m, 1H), 2.12-2.00 (m, 1H), 1.72-1.59 (m, 1H), 1.47-1.36 (m, 1H); 
13
C NMR (75.5 
MHz, CDCl3) δ 159.9, 148.0, 146.4, 140.2, 129.3, 128.5, 128.4, 127.2, 127.0, 126.9, 126.4, 123.8, 119.1, 
77.2, 68.0, 57.0, 49.4, 30.0, 26.2; HRMS (EI) calcd for C25H24N2O2: 384.1847; found: 384.1838.   
 
(5S,7aS)-5-Methyl-2-(perfluorophenyl)tetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-one (199).                                 
A solution of 186 (200 mg, 1.43 mmol) in DMF (5 mL) at 0 °C was 
transferred by cannula into a stirred suspension of sodium hydride (68 mg, 
2.87 mmol) in DMF (5 mL) at 0 °C, after 45 min hexafluorobenzene (0.17 
mL, 1.44 mmol) was added into mixture at 0 °C, the mixture was thereafter allowed to stir to at room 
temperature for 16 h. After cooling to 0 °C in an ice-water bath, workup was performed by sequential 
addition of NH4Cl (20 mL) and water (80 mL), and extracted with CH2Cl2 (4 × 10 mL). The combined 
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organic phase was dried over anhyd. Na2SO4, filtered and concentrated under reduced pressure. Flash 
column chromatography (silica gel, 9:1 hexane : EtOAC, Rf = 0.59) gave 199 as a colourless oil (212 mg, 
48%); [α]D
20
 ‒ 56.1 (c 3.5, CHCl3); IR (KBr) νmax 2944, 2877, 1706, 1651, 1505, 1397, 1308, 1168, 982, 
748 cm
-1
; 
1
H NMR (300 MHz, CDCl3): δ 4.24-4.14 (m, 1H), 3.85-3.76 (m, 2H), 3.65 (t, 1H,  J = 8.3 Hz), 
2.82-2.20 (m, 1H), 2.12-2.03 (m, 1H), 1.88-1.79 (m, 1H), 1.75-1.65 (m, 1H), 1.43 (d, 3H, J = 7.12 Hz); 
13
C NMR (75.5 MHz, CDCl3); δ 156.4, 144.1 (d, 
1
J 
13
 C- 
19
 F = 251.3 Hz), 140.1 (d, 
1
J 
13
 C- 
19
 F = 253.8 
Hz), 137.9 (d, 
1
J 
13
 C- 
19
 F = 251.3 Hz), 114.9-114.5 (m), 58.6, 52.2, 35.5, 29.6, 29.6, 18.1; 
19
F NMR 
(282.4 MHz, CDCl3); ‒144.9, ‒156.8, ‒162.5; HRMS (EI) calcd for C13H11F5N2O: 306.0789; found: 
306.0792.       
 
(Z)-N-((5S,7aS)-2-Methyl-5-(trimethylsilyl)tetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-ylidene)-1-
phenylmethanamine (202).  
A solution of 191 (119 mL, 0.56 mmol) in POCl3 (0.5 mL) in a sealed tube 
under argon was heated to 110 °C. After 16 h, the mixture was cooled to room 
temperature and the excess POCl3 was removed by under reduced pressure. The 
crude intermediate was dissolved in MeCN (0.5 mL) and transferred to a 
solution of benzylamine (0.07 mL, 0.67 mmol) and triethylamine (0.16 mL, 1.12 mmol) in MeCN (0.5 
mL) at 0 °C. The mixture was stirred for 1 h, made acidic by addition of 5% aqueous HCl (10 mL), and 
extracted with CH2Cl2 (3 × 10 mL). After evaporation of the combined organic extract, the residue was 
dissolved in water (15 mL) and washed with toluene (3 × 10 mL). The aqueous phase was made alkaline 
with 10% aqueous NaOH and extracted with CH2Cl2 (4 × 15 mL). The combined organic extract was 
dried over anhyd. Na2SO4, filtered, and concentrated under reduced pressure to yield 202 as a colorless oil 
(57 mg, 35%); [α]D
20
 +54.6 (c 0.6, CHCl3); IR (KBr, neat) νmax 2955, 1675, 1481, 1397, 1319, 1256, 1010 
, 889 cm
-1
; 
1
H NMR (300 MHz, DMSO-d6): δ 7.28 (dd, 4H, J = 7.8, 6.6 Hz), 7.15 (t, 1H, J = 6.18 Hz), 
4.58 (d, 1H, J = 15.5 Hz), 4.39 (d, 1H, J = 15.5 Hz), 3.76 (s, 1H), 3.33 (t, 1H, J = 8.7 Hz), 3.17 (dd, 1H, J 
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= 5.5, 3.6 Hz), 2.76 (s, 4H), 2.09-1.93 (m, 2H), 1.83 (s, 1H), 1.54-1.41 (m, 1H), 0.06 (s, 9H); 
13
C NMR 
(75.5 MHz, DMSO-d6); δ 157.4, 143.9, 128.1, 127.5, 126.0, 59.7, 56.2, 52.1, 51.2, 40.8, 30.8, 29.5, 0.38; 
EIMS [m/z(%)] 302 (M
+
, 2), 228 (40), 91(100). HRMS (EI) calcd for C17H27N3Si: 301.1974; found: 
301.1982.  
 
(5S,7aS)-2-Methyl-5-(trimethylsilyl)tetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-imine (205).  
A solution of 191 (10 mg, 0.47 mmol) in POCl3 (0.5 mL) in a sealed tube under 
argon was heated to 110 °C. After 16 h, the mixture was cooled to room 
temperature and the excess POCl3 was removed under reduced pressure. The 
crude intermediate was dissolved in MeCN (0.5 mL) and transferred to a solution of aqueous ammonia 
(0.18 mL, 4.57 mmol) and triethylamine (2.55 mL, 18.00 mmol) in MeCN (0.5 mL) at 0 °C. The mixture 
was stirred for 1 h, made acidic by addition of 5% aqueous HCl (10 mL), and extracted with CH2Cl2 (3 × 
10 mL). After evaporation of combined organic solution, the residue was dissolved in water (15 mL) and 
washed with toluene (3 × 10 mL). The aqueous phase was made alkaline with 10% aqueous NaOH and 
extracted with CH2Cl2 (4 × 15 mL). The combined organic extract was dried over anhyd. Na2SO4, 
filtered, and concentrated under reduced pressure to yield 205 as colorless oil (29 mg, 30%) [α]D
20
 ‒18.6 
(c 0.35, CHCl3); IR (KBr, neat) νmax 3428, 2946, 1641, 1490, 1407, 1301, 1024, 973, 904, 840, 755, 593 
cm
-1
; 
1
H NMR (300 MHz, acetone-d6): δ 3.62-3.55 (m, 1H), 3.39 (dd, 1H, J = 7.26, 1.5 Hz), 3.12 (dd, 1H, 
J = 3.3, 2.7 Hz), 2.90 (s, 1H), 2.65 (s, 3H), 2.46-2.4 (m, 1H), 1.86-1.81 (m, 2H), 1.60-1.42 (m, 2H), 0.15 
(s, 9H); 
13
C NMR (75.5 MHz, acetone-d6); δ 163.1, 59.4, 53.8, 52.0, 32.8, 30.9, 28.5, ‒0.3; EIMS 
[m/z(%)] 212 (M
+
, 4.8), 196 (100), 138 (62), 73 (35). HRMS (EI) calcd for C10H21N3Si: 211.1505; found: 
211.1493. 
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(5S,7aS)-5-Methyl-2-phenyltetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-imine (206).  
A solution of 166 (218 mg, 1.02 mmol) in POCl3 (1 mL) in a sealed tube under 
argon was heated to 110 °C. After 16 h, the mixture was cooled to room 
temperature and the excess POCl3 was removed under reduced pressure. The crude 
intermediate was dissolved in MeCN (1 mL) and transferred to a solution of aqueous ammonia (0.53 mL, 
10.00 mmol) and triethylamine (6.75 mL, 40.0 mmol) in MeCN (1 mL) at 0 °C. The mixture was stirred 
for 1 h, made acidic by addition of 5% aqueous HCl (10 mL), and extracted with CH2Cl2 (3 × 10 mL). 
After evaporation of combined organic solution, the residue was dissolved in water (15 mL) and washed 
with toluene (3 × 10 mL). The aqueous phase was made alkaline with 10% aqueous NaOH and extracted 
with CH2Cl2 (4 × 15 mL). The combined organic extract dried over anhyd. Na2SO4, filtered, and 
concentrated under reduced pressure to yield 206 as colorless oil (82 mg, 41%) [α]D
20
 –49.0 (c 0.35, 
CHCl3); IR (KBr, neat) νmax 3457, 2919, 2057, 1629, 1500, 1153, 1018 cm
-1
; 
1
H NMR (300 MHz, CDCl3) 
δ 7.40-7.35 (m, 4H) 7.10-7.05 (m, 1H), 4.17-4.05 (m, 1H), 4.05-3.95 (m, 1H), 3.84 (t, 2H, J = 8.8 Hz), 
3.65 (t, 1H, J = 8.5 Hz), 2.31-2.18 (m, 1H), 2.13-2.04 (m, 1H), 1.86-1.78 (m, 1H), 1.74-1.60 (m, 1H), 
1.44 (d, 3H, J = 6.4 Hz); 
13
C NMR (75.5 MHz, CDCl3) δ 156.4, 141.0, 129.2, 123.1, 120.1, 58.6, 55.2, 
52.1, 36.2, 28.7, 18.0; EIMS [m/z(%)] 215 (M
+
, 6), 160 (100), 106 (30); HRMS (EI) calcd for C13H17N3: 
215.1422; found: 215.1421.  
(5S,7aS)-2-Phenyl-5-(trimethylsilyl)tetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-imine (207).  
A solution of 194 (230 mg, 0.87 mmol) in POCl3 (1 mL) in a sealed tube under 
argon was heated to 110 °C. After 16 h, the mixture was cooled to room 
temperature and the excess POCl3 was removed by under reduced pressure. The 
crude intermediate was dissolved in MeCN (1 mL) and transferred to a solution of aqueous ammonia 
(0.63 mL, 8.50 mmol) and triethylamine (5.77 mL, 33.30 mmol) in MeCN (1 mL) at 0 °C. The mixture 
was stirred for 1 h, made acidic by addition of 5% aqueous HCl (10 mL), and extracted with CH2Cl2 (3 × 
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10 mL). After evaporation of the combined organic extract, the residue was dissolved in water (15 mL) 
and washed with toluene (3 × 10 mL). The aqueous phase was made alkaline with 10% aqueous NaOH 
and extracted with CH2Cl2 (4 × 15 mL). The combined organic extract was dried over anhyd. Na2SO4, 
filtered, and concentrated under reduced pressure to yield 207 as a colorless oil (78 mg, 34%); [α]D
20
 –
19.3 (c 0.6, CHCl3); IR (KBr, neat) νmax 3384, 2929, 1646, 1596, 1502, 1405, 1319, 1240, 1116 cm
-1
; 
1
H 
NMR (300 MHz, CDCl3) δ 7.42-7.39 (m, 2H), 7.31-7.25 (m, 2H), 7.19-7.09 (m, 1H), 3.99-3.86 (m, 2H), 
3.64-3.60 (m, 1H), 2.90-2.85 (m, 1H), 2.14-2.02 (m, 2H), 1.93-1.82 (m, 1H), 1.70-1.59 (m, 2H), 0.23 (s, 
9H); 
13
C NMR (75.5 MHz, CDCl3) δ 158.6, 141.2, 129.3, 123.5, 121.0, 58.8, 53.3, 51.2, 31.0, 29.2, 0.1; 
EIMS [m/z(%)] 273 (M
+
, 9), 258 (100), 200 (72), 182 (47), 73 (44); HRMS (EI) calcd for C15H23N3Si: 
273.1661; found: 273.1669. 
 
(E)-N-((5S,7aS)-5-Methyl-2-phenyltetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-ylidene)-1-
phenylmethanamine (203).  
A solution of 166 (110 mg, 0.51mmol) in POCl3 (1 mL) in a sealed tube under 
argon was heated to 110 °C. After 16 h, the mixture was cooled to room 
temperature and the excess POCl3 was removed under reduced pressure. The crude 
intermediate was dissolved in MeCN (1 mL) and transferred to a solution of 
benzylamine (0.07 mL, 0.61 mmol) and triethylamine (0.14 mL, 1.02 mmol) in MeCN (1 mL) at 0 °C. 
The mixture was stirred for 1 h, made acidic by addition of 5% aqueous HCl (10 mL), and extracted with 
CH2Cl2 (3 × 10 mL). After evaporation of combined organic solution, the residue was dissolved in water 
(15 mL) and washed with toluene (3 × 10 mL). The aqueous phase was made alkaline with 10% aqueous 
NaOH and extracted with CH2Cl2 (4 × 15 mL). The combined organic extract dried over anhyd. Na2SO4, 
filtered, and concentrated under reduced pressure to yield 203 as colorless oil (95 mg, 61%) [α]D
20
 –49.0 
(c 0.35, CHCl3); IR (KBr, neat) νmax 2996, 1683, 1517, 1469, 1332, 1195, 1006, 782, 640, 497 cm
-1
; 
1
H 
NMR (300 MHz, CDCl3): δ 7.81-7.78 (d, 2H, J = 7.9 Hz), 7.56-7.53 (d, 2H, J = 7.4 Hz), 7.42-7.25 (m, 
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5H), 7.39-6.96 (t, 1H, J = 7.4 Hz), 4.71 (d, 1H, J = 15.8 Hz), 4.53 (d, 1H, J = 15.8 Hz), 4.20-4.04 (m, 
2H), 3.92 (t, 1H, J = 8.3 Hz), 3.64 (t, 1H, J = 8.9 Hz),  2.42-2.30 (m, 1H),  2.22-2.13 (m, 1H), 1.95 (dd, 
1H, J = 5.7, 6.5 Hz), 1.87-1.79 (m, 1H), 1.18 (d, 3H, J = 6.4 Hz) ; 
13
C NMR (75.5 MHz, CDCl3); δ 152.7, 
143.1, 142.3, 128.4, 128.1, 127.4, 125.9, 121.1, 118.6, 58.4, 55.8, 55.0, 52.9, 35.5, 28.6, 19.3. ; EIMS 
[m/z(%)] 305 (M
+
, 38), 250 (53), 215 (37), 160 (100), 105 (66), 91 (84), 77 (70). HRMS (EI) calcd for 
C20H23N3: 305.1892; found: 305.1895.  
 
2-((E)-((5S,7aS)-5-Methyl-2-phenyltetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-
ylidene)amino)ethanol (204).  
A solution of 166 (190 mg, 0.88 mmol) in POCl3 (1 mL) in a sealed tube under 
argon was heated to 110 °C. After 16 h, the mixture was cooled to room 
temperature and the excess POCl3 was removed under reduced pressure. The crude 
intermediate was dissolved in MeCN (1 mL) and transferred to a solution of ethanolamine (0.07 mL, 0.61 
mmol) and triethylamine (0.14 mL, 1.02 mmol) in MeCN (1 mL) at 0 °C. The mixture was stirred for 1 h, 
made acidic by addition of 5% aqueous HCl (10 mL), and extracted with CH2Cl2 (3 × 10 mL). After 
evaporation of combined organic solution, the residue was dissolved in water (15 mL) and washed with 
toluene (3 × 10 mL). The aqueous phase was made alkaline with 10% aqueous NaOH and extracted with 
CH2Cl2 (4 × 15 mL). The combined organic extract dried over anhyd. Na2SO4, filtered, and concentrated 
under reduced pressure to yield 204 as colorless oil (71 mg, 31 %) [α]D
20
 +10.1 (c 0.35, CHCl3); IR (KBr, 
neat) νmax 3394, 2939, 1639, 1596, 1502, 1400, 1259, 1189, 1145, 1016, 892, 752, 514 cm
-1
; 
1
H NMR 
(300 MHz, CDCl3): δ 7.61 (d, 2H, J = 7.8 Hz), 7.31 (dd, 2H, J = 8.9 Hz),  6.96 (t, 1H, J = 7.3 Hz), 4.14-
4.06 (m, 1H), 3.96-3.87 (m, 2H), 3.81-3.75 (dd, 2H, J = 7.0, 4.6 Hz), 3.61 (t, 1H, J = 9.0 Hz), 3.52-3.34 
(m, 2H), 2.84 (b, 1H), 2.37-2.24 (m, 1H), 2.19-2.11 (m, 1H), 1.92 (dd, 1H, J = 6.6, 5.2 Hz), 1.86-1.74 (m, 
1H), 1.09 (d, 3H, J = 6.4 Hz) ; 
13
C NMR (75.5 MHz, CDCl3); δ 153.6, 142.0, 128.5, 121.6, 118.9, 63.4, 
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58.3, 55.8, 54.5, 50.5, 35.4, 28.5, 19.2 ; EIMS [m/z(%)] 259 (M
+
, 10.4), 228 (100 ), 153 (12). HRMS (EI) 
calcd for C15H21N3O: 259.1682; found: 259.1684.  
 
 (+)-(S)-2-Bromo-1-phenylethanol (99).  
A solution of guanidine 205 (27 mg, 0.10 mmol) in toluene (3 mL) at room 
temperature was treated with added BH3•SMe2 (0.50 mL, 0.50 mmol). After stirring 
at room temperature for 20 min, the reaction was mixture heated at 110 °C for 20 
min. A solution of phenacyl bromide (100 mg, 0.50 mmol) in toluene (2 mL) was added slowly, and 
heating was continued for a further 20 min. After cooling to room temperature, the reaction mixture was 
quenched with MeOH (1 mL) and the solvent was removed under reduced pressure. Flash column 
chromatography (9:1 hexane:EtOAc) gave (R)-99 as a colorless oil (84 mg, 83%); [α]D
20
 +3.6 (c 1.00, 
CHCl3) [lit.
83
 [α]D
25
 –39.0 (c 8.00, CHCl3) for (R) enantiomer]; CSP HPLC analysis (Chiralcel OD-H, 
90:10 hexanes:i-PrOH, 1.0 mL/min) determined an er of 54:46 (8% ee) [tR(major) = 7.77 min, tR(minor) = 
9.03 min]; 
1
H NMR (300 MHz, CDCl3) δ 7.49–7.34 (m, 5H), 5.01–4.85 (m, 1H), 3.69–3.48 (m, 2H), 2.64 
(b, 1H). 
 
(–)-(S)-1-Phenylethanol (220b).  
A solution of guanidine 207 (27 mg, 0.10 mmol) in toluene (1 mL) at room temperature 
was treated with added BH3•SMe2 (0.50 mL, 0.50 mmol). After stirring at room 
temperature for 20 min, the reaction mixture was heated at 110 °C for 20 min. A 
solution of acetophenone (0.06 mL, 0.50 mmol) in toluene (1 mL) was added slowly, and heating was 
continued for a further 20 min. After cooling to room temperature, the reaction mixture was quenched 
with MeOH (1 mL) and the solvent was removed under reduced pressure. Flash column chromatography 
(9:1 hexane:EtOAc) gave (S)-220b as a colorless oil (47 mg, 77%); [α]D
20
 –10.1 (c 2.00, CHCl3) [lit.
84
 
[α]D
25
 –57.0 (c 5.13, CHCl3) for (S) enantiomer]; CSP HPLC analysis (Chiralcel OD-H, 95:5 hexanes:i-
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PrOH, 0.4 mL/min) determined an er of 62:38 (24% ee) [tR(minor) = 19.49 min, tR(major) = 23.72 min]; 
1
H NMR (300 MHz, CDCl3) δ 7.38–7.28 (m, 5H), 4.95–4.90 (m, 1H), 1.80-1.79 (b, 1H), 1.44 (d, 3H, J = 
6.5 Hz). 
 
(5S,7aS)-5-Methyl-2-phenylhexahydro-1H-pyrrolo[1,2-c]imidazole (167).  
A solution of 166 (600 mg, 2.77 mmol) in THF (150 mL) at –78 °C was treated 
with DIBAL-H (24 mL, 1.00 M, 22.22 mmol) and the mixture was allowed to stir at 
room temperature for 16 h. The reaction mixture was cooled in an ice-water bath, worked up by addition 
of saturated solution of potassium sodium tartrate (10 mL) and water (135 mL), and extracted with CH2Cl2 
(4 × 100 mL). The combined organic phase was dried over anhyd. Na2SO4, filtered and concentrated 
under reduced pressure. Flash column chromatography (silica gel, 97:3 EtOAc: Et3N, Rf = 0.27) gave 167 
as a colorless oil (289 mg, 52%); [α]D
20
 +14.2 (c 1, CHCl3); IR (KBr, neat) νmax 3053, 3039, 2953, 2904, 
2870, 2836, 1596, 1504, 1365, 1341, 1154, 1120, 992, 742, 688, 511 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 
7.26 (t, 2H, J = 8.1 Hz), 6.74 (t, 1H, J = 7.5 Hz), 6.57-6.54 (d, 2H, J = 8.0 Hz), 4.37-4.30 (d, 1H, J = 6.8 
Hz), 4.13 (d, 1H, J = 6.8 Hz), 3.91-3.85 (m, 1H), 3.52-3.40 (m, 2H), 3.11-3.07 (m, 1H), 2.20-2.07 (m, 
1H), 2.04-1.93 (m, 1H), 1.87-1.70 (m, 1H), 1.68-1.62 (m, 1H), 1.3 (d, 3H, J = 6.8 Hz) ; 
13
C NMR (75.5 
MHz, CDCl3) δ 146.7, 129.2, 116.6, 112.4, 64.4, 63.8, 58.0, 53.7, 32.2, 30.0, 16.9; EIMS [m/z(%)] 217 
(M
+
, 14), 201 (74), 69 (100), 55 (48). HRMS (EI) calcd for C13H18N2: 216.1262; found: 216.1262.  
 
(5S,7aS)-5-Methyl-2-phenyl-1,2,5,6,7,7a-hexahydropyrrolo[1,2-c]imidazol-4-ium tetraphenylborate 
(168).   
  A solution of 167 (202 mg, 1.00 mmol) and tritylium tetrafluoroborate (330 mg, 
1.00 mmol) in CH2Cl2 (12 mL) was stirred at room temperature for 16 h in a 
sealed tube under argon. The mixture was cooled to room temperature and 
CH2Cl2 was removed under reduced pressure. The crude mixture was dissolved in MeOH (3 mL), and a 
solution of NaBPh4 (342 mg, 1.00 mmol) in MeOH (3 mL) was added dropwise. The resulting precipitate 
86 
 
was filtered, washed with cold  MeOH and dried under high vacuum to give 168 as a beige powder (33 
mg, 63%); mp 189-192 °C; [α]D
20
 +149.0 (c 0.5, CHCl3); IR (KBr) νmax 3051, 1608, 1587, 1502, 1477, 
1425, 1315, 1280, 1251, 1135, 1066, 1031, 1007, 946, 847, 823, 734, 705, 604, 512  cm
-1
; 
1
H NMR (300 
MHz, acetone-d6): 9.15 (s, 1H), 7.68 (d, 1H, J = 8.3 Hz), 7.36 (d, 11H, J = 5.8 Hz), 6.94 (t, 9H, J = 7.0 
Hz), 6.80 (t, 4H, J = 7.2 Hz), 4.79-4.70 (m, 1H), 4.50-4.35 (m, 2H), 4.15 (d, 1H, J = 6.5 Hz), 2.50-2.25 
(m, 2H), 2.01-1.81 (m, 2H), 1.60 (d, 3H, J = 6.2 Hz); 
13
C NMR (75.5 MHz, acetone-d6): 164.3 (q, J
13
C-
11
B = 49.2 Hz), 152.2, 136.1, 132.7, 129.8, 125.2, 125.1, 121.4, 119.9, 64.6, 64.5, 54.9, 54.2, 33.4, 18.2; 
FABMS [m/z(%)] 201 (M–BPh4, 100), 149 (9), 41 (84); HRMS (ESI) calcd for C13H17N2: 201.1398; 
found: 201.1392. 
Chloro(ɳ4-1,5-cyclooctadiene)(5-methyl-2-phenylhexahydro-1H-pyrrolo[1,2-c]imidazolidine- 
2-ylidene)rhodium (240).                                    
  A solution of 168 (50 mg, 0.10 mmol) and [Rh(COD)Cl]2 (25 mg, 0.05 mmol) in 
THF (2 mL) was stirred at -78 °C in a sealed tube under argon. After 30 min 
sodium hydride (5 mg, 60% dispersion in mineral oil, 0.12 mmol) was added. The 
mixture was stirred at room temperature for 16 h, during which time the color 
changed from orange to brown. After removing the solvent on a rotary evaporator, the crude product was 
purified by column chromatography (silica gel, 7:3 hexane:EtOAc, Rf = 0.21) gave 240 as a 56:44 
mixture of coordination isomers as an orange-yellow oil in a 3:1 ratio. (25 mg, 58%); [α]D
20
 –21.0 (c 1.5, 
CHCl3); IR (KBr, neat) νmax 3341, 3047, 2920, 2870, 2828, 2116, 1943, 1598, 1555, 1494, 1469, 1364, 
1230, 1183, 1084, 1021, 995, 958, 863, 814, 756, 694, 644, 516 cm
-1
; Main isomer: 
1
H NMR (300 MHz, 
CDCl3) δ 8.07 (d, 1H, J = 7.7 Hz), 7.47-7.39 (m, 2H), 7.25-7.17 (m, 2H), 5.15-5.08 (m, 1H), 5.03-4.96 
(m, 1H), 4.36-4.20 (m, 1H), 4.16-3.96 (m, 1H), 3.79-3.72 (m, 2H), 3.24-3.18 (m, 1H), 2.51-2.14 (m, 3H), 
2.23 (d, 3H, J = 6.5 Hz), 2.07-1.54 (m, 10H), 
13
C NMR (75.5 MHz, CDCl3) δ 204.6, 143.5, 128.3, 124.8, 
120.8, 97.7, 97.4, 72.0, 69.7, 66.9, 65.4, 55.1, 51.7, 36.3, 32.1, 29.1, 28.6, 27.5, 22.4 ; EIMS [m/z(%)] 
446 (M
+
, 2.2), 411 (12.2), 302 (18.4 ), 201 (33.7), 55 (100). HRMS (EI) calcd for C21H28N2RhCl: 
446.1021; found: 446.1029.  
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Dicarbonylchloro)(5-methyl-2-phenylhexahydro-1H-pyrrolo[1,2-c]imidazolidine-2-ylidene)rhodium 
(242).                                   
To a solution of 240 (60 mg, 0.13 mmol) in DCM (7 mL) carbon monoxide was 
bubbled into the reaction mixture. The mixture was stirred at room temperature for 16 
h under CO atmosphere, during which time the color changed from orange to red. 
After removing the solvent on a rotary evaporator, the crude product was purified by 
column chromatography (silica gel, 7:3 hexane:EtOAc, Rf = 0.26) gave 242 as an orange-yellow oil 
mixture of rotamers in a roughly 10:1 ratio. (40 mg, 78%); [α]D
20
 –33.1 (c 1.8, CHCl3); IR (KBr, neat) 
νmax 3150, 2922, 2873, 2068, 1987, 1596, 1479, 1454, 1401, 1369, 1343, 1309, 1237, 1187, 754, 691, 
634, 579, 510 cm
-1
; Main isomer: 
1
H NMR (300 MHz, CDCl3) δ 7.69 (d, 1H, J = 7.49 Hz), 7.37 (t, 2H, J 
= 8.2 Hz), 7.28-7.22 (m, 2H), 4.54-4.40 (m, 1H), 4.29-4.22 (m, 1H), 4.06 (dd, 1H, J = 9.8, 3.2 Hz), 3.96-
3.81 (m, 1H), 2.53-2.39 (m, 1H), 2.20-2.14 (m, 1H), 2.05-1.99 (m, 1H), 1.83 (d, 3H, J = 7.0 Hz), 1.80-
1.74 (m, 1H) ; 
13
C NMR (75.5 MHz, CDCl3) δ 197.1 (d, J = 40.1 Hz), 186.2 (d, J = 55.0 Hz), 182.8 (d, J 
= 75.1 Hz), 142.2, 128.6, 125.7, 121.4, 66.8, 55.7, 51.8, 36.2, 28.0, 23.9; HRMS (EI) [M-Cl-2CO] calcd 
for C15H16ClN2O2Rh: 303.0356; found: 303.0369.     
 
2-Methyl-3-phenylpropan-1-ol (245).  
A solution of 242 (4 mg, 0.01 mmol, 0.2 mol%), allyl benzene 243 (0.07 mL, 0.5 
mmol) and (triphenyl phosphite (0.02 mL, 0.01 mmol, 2 mol%) in toluene (2 ml) 
was placed into the bomb under 20 bar of CO/H2 pressure at 60 °C and stirred for 48 h. The crude 
reaction was dissolved in EtOH (4 ml) and NaBH4 (111 mg, 3.00 mmol) was added. The reaction mixture 
was stirred at room temperature for 4 h and worked up by careful addition of 5% aqueous HCl (4 mL). 
The crude mixture was extracted with CH2Cl2 (3 × 10 mL), and the combined organic phase was dried 
over anhyd. Na2SO4, filtered and concentrated under reduced pressure. Flash column chromatography 
(silica gel, 4:1 hexane:EtOAC, Rf = 0.41) gave combined yield of both branched and linear alcohols as a 
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colourless oil (212 mg, 54%); 
1
H NMR (300 MHz, CDCl3): δ 3.59-3.47 (m, 2H), 2.79 (dd, 1H, J = 13.4, 
6.3 Hz), 2.44 (dd, 1H, J = 13.4, 8.1 Hz,), 2.03-1.94 (m, 1H), 1.45 (br, 1H), 0.94 (d, 3H, J = 6.8 Hz).  
 
4-phenylbutan-1-ol (244). 
1
H NMR (300 MHz, CDCl3): δ 7.33-7.20 (m, 5H), 3.68 (t, 2H, J = 6.5 Hz), 
2.67 (t, 2H , J = 7.6 Hz), 1.76- 1.61 (m, 4H), 1.45 (br s, 1H).  
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# RetTime Type 
Area 
mAU 
Height 
Width Area % 
1 19.83377 VV   22398.41 619.572 0.538247 31.5205 
2 24.15722 VB   21041.6 522.803 0.626804 29.6111 
# RetTime Type 
Area 
mAU Height Width Area % 
18 19.90253 VV   28356.77 766.5344 0.548071 43.4743 
20 24.45084 VBA  34494.92 767.499 0.716545 52.8848 
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# RetTime Type 
Area 
mAU Height Width Area % 
9 19.48777 BB   4009.38 119.875 0.506687 28.9892 
10 23.72072 BV   6339.506 158.7509 0.605669 45.8369 
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